Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,35977,343,0.86 [0.47-1.58],0.6272139393265689
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,34974,334,0.88 [0.72-1.08],0.2346321873225081
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,41125,401,0.89 [0.76-1.05],0.1760509473500288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,34795,332,1.09 [0.81-1.47],0.5554172443102511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,40878,396,0.94 [0.80-1.10],0.4347440497602881
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,41125,401,1.02 [0.89-1.16],0.7916505431876637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,35947,342,1.02 [0.95-1.10],0.5124885761364822
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,34795,332,0.98 [0.83-1.15],0.8182678278603677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",40382,393,1.01 [0.91-1.13],0.8213785095623458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",35263,335,0.92 [0.78-1.08],0.3130267740678457
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",35921,340,0.92 [0.82-1.04],0.1968602274345837
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,40915,399,1.06 [0.77-1.47],0.725785728444612
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,35947,342,1.20 [0.82-1.74],0.3501227656906506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,40589,398,1.16 [0.99-1.36],0.0742320417699825
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,35152,331,1.07 [0.78-1.45],0.6888894615461905
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,35768,339,0.97 [0.89-1.07],0.5618008145549254
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,41323,407,1.08 [0.91-1.28],0.3857646463916695
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,34891,335,0.83 [0.65-1.05],0.124791788595669
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,41513,412,1.30 [1.00-1.68],0.0497025030237822
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,41635,407,1.00 [0.88-1.14],0.9862129107391416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,35757,338,1.01 [0.78-1.30],0.9679509833972626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,34891,335,0.96 [0.86-1.08],0.5105963215287108
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,34795,332,0.76 [0.54-1.06],0.1084795780722195
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",40589,398,1.11 [0.91-1.35],0.2909451794811778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,34795,332,1.22 [1.04-1.43],0.0172499241502544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,40581,397,0.94 [0.71-1.26],0.6826500586598538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,40949,400,1.26 [0.89-1.78],0.1886847481325136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,41323,407,1.05 [0.91-1.22],0.4856616046807932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,34795,332,1.06 [0.88-1.29],0.5300944058185849
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,35021,331,0.99 [0.84-1.16],0.8992168393480415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,41794,410,0.83 [0.64-1.07],0.1432542542913256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,41084,406,1.03 [0.84-1.26],0.8032065832569334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,34891,335,1.05 [0.76-1.45],0.7812014929011921
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40589,398,1.00 [0.75-1.33],0.9867736595944372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,41018,400,1.06 [0.83-1.35],0.660437922476875
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,41794,410,1.01 [0.79-1.30],0.930409531847226
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,41618,409,1.06 [0.78-1.44],0.7175683883777978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,35768,339,1.32 [0.94-1.86],0.1132908085004185
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,34891,335,1.32 [0.98-1.78],0.0717569748235308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,41828,413,1.11 [0.77-1.61],0.57170235374176
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,41125,401,1.04 [0.84-1.29],0.7315468237165585
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40589,398,1.15 [0.91-1.46],0.2455772556890026
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,34891,335,1.21 [0.91-1.62],0.1949631353516013
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,41438,410,0.97 [0.80-1.18],0.7777278762889757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,35930,344,1.34 [1.00-1.81],0.0530101733807787
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,34974,334,1.07 [0.69-1.67],0.7679688748609136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,35921,340,0.82 [0.63-1.06],0.1328399696142733
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,40382,393,0.94 [0.71-1.24],0.6454083318132884
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,35152,331,0.89 [0.77-1.04],0.133658460534992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,40949,400,1.09 [0.83-1.42],0.533154110306884
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,35152,331,1.26 [0.97-1.64],0.0816848591244325
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,35768,339,1.06 [0.88-1.29],0.5310289716425685
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,41484,405,1.07 [0.78-1.46],0.6738631661601543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,41630,412,1.06 [0.80-1.41],0.6851341863988349
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,35921,340,1.09 [0.75-1.60],0.6479529791943961
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,41125,401,1.11 [1.00-1.23],0.0409039819896846
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,41323,407,0.78 [0.56-1.08],0.1352873994958889
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,34824,331,0.99 [0.85-1.15],0.8537183400385605
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,35152,331,0.94 [0.82-1.09],0.4420634987688114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40589,398,1.06 [0.95-1.18],0.3331603080003548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,35977,343,0.96 [0.83-1.12],0.6236225776337908
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,41698,408,1.22 [0.87-1.73],0.2495475008557383
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,34795,332,1.03 [0.89-1.19],0.6804050703677038
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,35152,331,1.00 [0.88-1.14],0.9962065926434752
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AFM,Afamin,35977,343,1.12 [0.67-1.87],0.6632198435408871
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,40889,400,0.93 [0.82-1.07],0.331780685971281
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,34824,331,0.96 [0.86-1.07],0.4789704906330799
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,41209,402,1.00 [0.80-1.24],0.993031010944902
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,40032,397,1.12 [1.02-1.22],0.0128967418304693
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,40315,392,0.95 [0.81-1.11],0.5032878729610293
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,41484,405,1.31 [1.02-1.69],0.0330250288682615
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,41794,410,1.00 [0.84-1.18],0.981222529852668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,35947,342,0.92 [0.57-1.48],0.7254119503329834
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,41323,407,1.00 [0.89-1.13],0.9589160695769772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,41323,407,0.99 [0.87-1.12],0.8292032986378519
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,34974,334,0.80 [0.57-1.14],0.2164885832759597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,34974,334,1.07 [0.76-1.50],0.7164295112448533
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,35757,338,1.00 [0.86-1.17],0.9956249602537632
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,35947,342,1.38 [0.95-2.02],0.0934055959191101
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,41260,409,0.90 [0.81-1.01],0.0629115431838776
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",34963,333,0.99 [0.87-1.12],0.8560685137988644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,40382,393,0.86 [0.73-1.03],0.1010717521871361
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,34974,334,1.06 [0.88-1.27],0.5667637796281411
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",41054,398,1.02 [0.94-1.11],0.6044002878174786
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,41323,407,0.88 [0.76-1.01],0.070248707358644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",35854,341,1.02 [0.92-1.12],0.7285169098081212
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,35152,331,1.21 [0.75-1.95],0.4439389424445302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,40382,393,0.95 [0.84-1.08],0.4502214971932206
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,34963,333,1.14 [0.97-1.34],0.1014699861947676
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,40589,398,0.99 [0.83-1.18],0.93749000465094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,34891,335,1.03 [0.88-1.20],0.7042883628289852
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,40363,400,0.98 [0.85-1.12],0.7206643047438003
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,35870,341,0.99 [0.91-1.07],0.8058503509729866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,40187,392,1.04 [0.89-1.22],0.6224463919750352
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,41828,413,1.11 [0.71-1.74],0.6551999909766085
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,41333,409,0.87 [0.73-1.02],0.0936835437316728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",35757,338,1.07 [0.89-1.30],0.465470682931282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",41210,403,1.08 [0.96-1.22],0.1994611636961401
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",35870,341,0.95 [0.76-1.19],0.6712068017250645
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,35263,335,0.88 [0.68-1.13],0.3171684416015097
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,34891,335,1.06 [0.98-1.16],0.1520096893494936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",41125,401,1.11 [1.02-1.21],0.0131283016735527
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,40581,397,0.92 [0.65-1.30],0.6235009016511484
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,41639,408,1.29 [0.84-1.99],0.2505899477971128
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,35930,344,1.34 [0.89-2.00],0.1609858592174584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,40363,400,1.03 [0.89-1.18],0.7083310762019358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,34963,333,0.92 [0.73-1.15],0.4566788491003865
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,41125,401,1.01 [0.69-1.47],0.9752355189054268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,40581,397,1.22 [1.01-1.46],0.035661473757883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,35152,331,1.21 [0.92-1.60],0.1640623565631411
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,35630,335,0.99 [0.79-1.23],0.91178024699453
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,35854,341,0.91 [0.79-1.06],0.2251326192920461
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,33640,317,0.98 [0.79-1.22],0.8567142063080954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,39748,396,0.95 [0.79-1.14],0.5792029495616025
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,38529,383,1.00 [0.83-1.20],0.9590907117985022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,41220,411,1.33 [1.04-1.72],0.0257482789185347
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,41163,402,0.99 [0.89-1.10],0.8898152008066011
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,41698,408,1.24 [0.99-1.56],0.0609249234312752
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,40732,398,1.29 [0.95-1.75],0.1088176177626646
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,41348,404,0.94 [0.75-1.17],0.5860819463036832
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,41347,411,0.92 [0.72-1.18],0.501179757935486
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,41423,404,1.25 [1.03-1.52],0.0271741557115697
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,41698,408,1.16 [0.91-1.48],0.2324133146059724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,34795,332,1.00 [0.86-1.16],0.9782862960056564
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,34891,335,1.02 [0.90-1.17],0.7528187467118672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,34667,329,1.03 [0.85-1.24],0.7492244840915883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,40382,393,0.83 [0.70-0.98],0.0308569103674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,34974,334,0.89 [0.66-1.19],0.4184999760786678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,41411,410,0.90 [0.65-1.25],0.5295907452454547
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,34947,330,0.92 [0.71-1.18],0.5041599116880692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,40363,400,1.10 [1.00-1.22],0.061092543354082
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,41206,402,0.92 [0.81-1.04],0.1959149480467439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,34455,329,1.10 [0.95-1.27],0.2048343722666823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,41618,409,0.98 [0.87-1.12],0.8069377663945952
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,41127,406,0.97 [0.86-1.10],0.6333966690367896
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,40237,397,1.10 [0.82-1.48],0.5166070073609121
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],40581,397,1.00 [0.85-1.17],0.9898463873206232
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,41479,412,1.32 [0.98-1.77],0.0641417201510788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,35757,338,0.96 [0.84-1.09],0.5267450963114755
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,34963,333,0.98 [0.78-1.22],0.825905053755707
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,35768,339,0.95 [0.83-1.09],0.4903220386565523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,35854,341,0.99 [0.80-1.23],0.935389793169974
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,41125,401,0.91 [0.74-1.11],0.3483173847787777
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,35651,342,0.98 [0.72-1.34],0.9135078310080254
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,41573,407,0.91 [0.78-1.06],0.2310028281033429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,41323,407,0.92 [0.78-1.10],0.3646237483267959
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,35977,343,1.10 [0.75-1.60],0.6334093450655847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,35947,342,1.11 [0.90-1.37],0.3211636726394226
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,35977,343,1.26 [0.95-1.66],0.1023237909972212
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,35947,342,1.16 [0.74-1.83],0.514578028829874
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,34974,334,0.87 [0.68-1.10],0.2449725108326083
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,35908,343,0.82 [0.61-1.09],0.1693211112214848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,34346,331,0.98 [0.75-1.28],0.8913452927448756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,35977,343,1.06 [0.92-1.22],0.4242631101810012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,35947,342,0.74 [0.50-1.10],0.1349463975815968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,41333,409,0.98 [0.77-1.25],0.8716739930756032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,35947,342,0.92 [0.75-1.12],0.3921743447928513
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,41419,411,0.72 [0.53-0.97],0.029998367377461
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,41273,407,0.94 [0.83-1.08],0.4003499029865174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,35152,331,0.97 [0.88-1.07],0.5303135319305878
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,40958,400,0.99 [0.82-1.20],0.9436739704041316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,35263,335,0.92 [0.78-1.07],0.2785688747316833
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,41125,401,1.33 [1.09-1.63],0.005775576181138
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,35768,339,0.93 [0.84-1.02],0.1124398851215217
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,35870,341,0.98 [0.84-1.14],0.815059666142992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,41123,403,0.84 [0.71-0.99],0.0372210423858977
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",35757,338,0.94 [0.73-1.21],0.6309729921828184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,40382,393,0.86 [0.71-1.04],0.1217485782804054
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,40382,393,0.93 [0.80-1.08],0.3591148950527519
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,35263,335,0.85 [0.63-1.14],0.2678683888382573
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,35152,331,0.99 [0.87-1.13],0.9267375298951198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,34667,329,1.09 [0.96-1.24],0.1827533472560203
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,35854,341,1.01 [0.90-1.13],0.8916691127443874
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,35870,341,0.97 [0.87-1.09],0.6289314053940592
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,41274,403,1.00 [0.92-1.09],0.9453756029137012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,34824,331,0.98 [0.85-1.14],0.7914495403765823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,34824,331,0.84 [0.64-1.11],0.2241567114015884
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,40363,400,0.75 [0.59-0.97],0.0292261809633609
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,34795,332,1.13 [0.98-1.30],0.095317283281155
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,34795,332,0.93 [0.71-1.21],0.5979482899521629
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,34824,331,0.95 [0.79-1.14],0.603119930082192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,40581,397,0.92 [0.71-1.19],0.5240698644109267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,34795,332,0.99 [0.81-1.21],0.9341577380232228
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,41333,409,1.11 [0.91-1.34],0.3042494426527108
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,41125,401,0.96 [0.82-1.13],0.6221742891919495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,41479,412,0.93 [0.72-1.19],0.5497098147628626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,34824,331,0.89 [0.73-1.07],0.2172400878216006
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,40581,397,1.10 [0.92-1.32],0.2995648935384104
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,35602,340,1.07 [0.86-1.34],0.5550016511249861
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,41018,400,0.99 [0.84-1.16],0.8824649876840045
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,41018,400,1.46 [1.10-1.94],0.0092327435825076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,35947,342,1.57 [1.07-2.29],0.0196086787867925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,35921,340,1.10 [0.77-1.57],0.5892302186174985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,35870,341,0.96 [0.82-1.12],0.6141420903115271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,34974,334,0.99 [0.89-1.10],0.8152899075231155
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,34795,332,0.95 [0.82-1.09],0.4273495515258345
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,40363,400,1.07 [0.95-1.20],0.2787886184900896
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,34667,329,1.14 [0.85-1.55],0.3787200399400114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,35768,339,1.00 [0.88-1.13],0.9569085017792804
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,40382,393,0.86 [0.74-1.00],0.0561271783059752
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,41438,410,0.95 [0.84-1.07],0.3927484370290582
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,34795,332,0.96 [0.76-1.21],0.7209992120384607
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,34795,332,0.89 [0.63-1.24],0.4859170181210382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,34795,332,1.01 [0.77-1.33],0.9273244781090876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,34667,329,1.08 [0.85-1.38],0.5167492449097232
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,34795,332,0.98 [0.82-1.16],0.8185223333161938
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",34795,332,1.17 [0.99-1.38],0.0596664379468139
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",41484,405,0.98 [0.90-1.06],0.5669092323564582
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",40363,400,1.20 [0.99-1.45],0.0698694736426579
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,40382,393,1.02 [0.81-1.27],0.8903130634722866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,41125,401,0.60 [0.42-0.87],0.0075870570769175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,40286,399,0.98 [0.86-1.13],0.8069575628945707
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,34974,334,0.92 [0.80-1.07],0.2870220495158178
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,34795,332,1.04 [0.93-1.15],0.526562182451828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,35768,339,1.20 [0.88-1.63],0.2417378884695301
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",35977,343,0.78 [0.42-1.45],0.4352903578835659
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,40363,400,1.04 [0.92-1.17],0.5755721541407164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,34824,331,1.02 [0.93-1.12],0.7001626899961684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,35870,341,1.32 [1.10-1.59],0.0026556053848515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,35854,341,0.92 [0.78-1.09],0.3448413596344203
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,41274,403,1.01 [0.92-1.10],0.8781694906929794
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,41479,412,0.93 [0.68-1.29],0.6809880249552235
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,35870,341,1.00 [0.83-1.20],0.9754228756532664
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,40060,399,0.87 [0.77-0.99],0.0335118619429011
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,35977,343,1.02 [0.74-1.41],0.899532025861355
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,34795,332,0.64 [0.37-1.09],0.0983666153014073
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",34974,334,0.95 [0.71-1.26],0.725895661474949
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",41484,405,1.33 [0.97-1.83],0.078963185738561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",41333,409,0.88 [0.62-1.27],0.5041523468378647
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,34891,335,0.99 [0.68-1.42],0.9370705247231692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,41274,403,0.99 [0.88-1.12],0.8825068438663375
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,40949,400,1.04 [0.83-1.30],0.744149597593024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,34891,335,1.11 [0.91-1.37],0.3060356150479464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,40589,398,1.03 [0.81-1.32],0.8002111269670495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,40382,393,0.99 [0.86-1.14],0.906175920884256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,40382,393,1.01 [0.74-1.39],0.9287673278623302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,41274,403,1.00 [0.92-1.09],0.9397186817898748
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,35854,341,1.04 [0.90-1.20],0.6202572171199721
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,34963,333,0.98 [0.86-1.11],0.7061049411230237
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,40301,398,0.97 [0.88-1.08],0.6008360154019622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,41333,409,0.79 [0.55-1.15],0.217626178597305
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,41018,400,0.84 [0.65-1.08],0.1683294120983888
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",35921,340,0.97 [0.69-1.37],0.8747482416618175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",34824,331,0.85 [0.69-1.07],0.1619372872232236
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,35279,341,1.23 [0.83-1.81],0.3088358530680802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,35768,339,1.09 [0.91-1.31],0.3371229946441674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,35854,341,0.98 [0.89-1.09],0.7425967655106138
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",41274,403,0.98 [0.79-1.20],0.8212543357256639
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,34891,335,0.93 [0.77-1.12],0.4596362420739132
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,34667,329,0.97 [0.81-1.14],0.6839321406136548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,35757,338,1.11 [0.90-1.37],0.321217544664656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,41274,403,0.99 [0.90-1.09],0.8392264353385769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,35930,344,0.97 [0.86-1.09],0.6128080972853504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,34974,334,0.93 [0.78-1.12],0.4470922507084799
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,34667,329,1.09 [0.87-1.36],0.4540302008172413
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,35930,344,0.91 [0.81-1.03],0.1459233842109477
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,40316,392,1.02 [0.95-1.10],0.608156057096106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,34824,331,0.99 [0.85-1.16],0.9252080644754336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,34795,332,1.18 [0.79-1.76],0.4272657502883138
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,41274,403,0.97 [0.85-1.11],0.6509566437066359
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,41333,409,0.94 [0.86-1.04],0.248790702029079
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,40382,393,1.01 [0.87-1.16],0.9039530152813456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,41828,413,0.91 [0.68-1.20],0.4890001191325326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,34891,335,1.50 [1.20-1.87],0.0003644440881003
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,34824,331,1.03 [0.90-1.18],0.6623525385875142
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,35854,341,1.03 [0.79-1.33],0.8370446775194464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,41333,409,0.87 [0.76-1.00],0.04714728233566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,35152,331,0.88 [0.61-1.27],0.5018290364773386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,40949,400,1.12 [0.93-1.35],0.2362254128341948
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,40523,398,1.08 [0.87-1.35],0.4928049052518363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,35152,331,1.74 [1.13-2.68],0.0125391605244036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,35921,340,1.11 [0.83-1.50],0.4819024182004889
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,34891,335,1.13 [0.89-1.44],0.3055309332923409
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,40589,398,1.29 [0.88-1.90],0.1934396352545897
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,34824,331,1.05 [0.87-1.27],0.6216798146705771
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,34974,334,0.85 [0.69-1.03],0.0934724177234126
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,33736,316,0.99 [0.89-1.09],0.7842723744969932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,41236,405,0.97 [0.85-1.12],0.6923394029747716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,35859,340,0.88 [0.74-1.04],0.134430115550024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,35435,338,0.96 [0.88-1.06],0.4527056857789608
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,35263,335,0.86 [0.60-1.24],0.4275742589162471
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,34824,331,0.81 [0.58-1.13],0.2116992984091083
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,34795,332,0.99 [0.80-1.23],0.9180806499902538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,34795,332,0.91 [0.68-1.22],0.524469092727397
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,40363,400,0.96 [0.79-1.18],0.709224468095625
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,34824,331,0.98 [0.75-1.28],0.8650047716600499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,35870,341,1.12 [0.86-1.47],0.3986141172364636
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BSG,Basigin,41720,409,1.27 [0.82-1.96],0.2867053107705964
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BSND,Barttin,34667,329,0.83 [0.60-1.17],0.29487266111323
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,41689,410,0.95 [0.80-1.13],0.5863994379145723
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,41689,410,1.04 [0.87-1.24],0.6896598699858192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,40382,393,0.99 [0.88-1.12],0.9007853901928056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,35977,343,1.10 [0.67-1.82],0.7051210463085724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,34667,329,1.04 [0.93-1.16],0.4719333395503677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,35689,338,1.10 [0.87-1.41],0.4255722619104523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,41484,405,1.20 [0.87-1.68],0.269934271388382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,41274,403,1.04 [0.82-1.32],0.7279032248994017
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,34667,329,0.90 [0.68-1.19],0.4631724568252751
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,40363,400,1.07 [0.94-1.22],0.3173592643170601
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,34795,332,1.17 [0.86-1.60],0.3071078141413362
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,41585,409,0.97 [0.65-1.43],0.8616126782439681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",35870,341,1.02 [0.89-1.17],0.7609616786389328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,34891,335,1.01 [0.79-1.29],0.9307324897389108
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,41479,412,1.02 [0.84-1.25],0.8202533355314298
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,35152,331,1.28 [0.96-1.72],0.0943235950533223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,35870,341,0.92 [0.67-1.28],0.6337332522606429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,35086,331,0.92 [0.74-1.14],0.4426811377990195
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,35977,343,1.61 [1.01-2.57],0.0454700862399368
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,35910,343,1.53 [0.89-2.61],0.1214134416781849
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,35977,343,1.34 [0.82-2.19],0.2381597378585411
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C2,Complement C2,41419,411,0.94 [0.64-1.37],0.7440080434642957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,40286,399,0.94 [0.75-1.16],0.5497989635120839
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,34963,333,0.96 [0.80-1.16],0.6745319644043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C3,Complement C3,34151,329,1.06 [0.84-1.34],0.6344884982204151
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,41438,410,1.17 [0.94-1.46],0.1600095483366488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C5,Complement C5,35977,343,1.65 [0.85-3.21],0.1403483397485553
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,35120,340,1.47 [1.05-2.05],0.0228728171592155
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,35854,341,1.10 [0.73-1.68],0.6415326006369764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,35977,343,1.09 [0.78-1.53],0.6154589887537502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,35947,342,0.98 [0.82-1.19],0.8589385468709152
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,35768,339,0.89 [0.78-1.02],0.0856717406894652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,40429,404,0.85 [0.73-0.98],0.029720947388102
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,40382,393,1.02 [0.76-1.37],0.8828591350649931
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,41125,401,1.19 [0.91-1.56],0.2026089748458518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,40857,401,0.97 [0.90-1.06],0.5412836667933429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,41698,408,0.83 [0.65-1.07],0.1492464193474871
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,41199,409,0.87 [0.76-0.99],0.0305520851480412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,41764,413,0.96 [0.83-1.11],0.6042775957295906
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,41828,413,1.13 [0.79-1.62],0.5038064099109483
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",40589,398,0.98 [0.89-1.08],0.6896332392342165
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,41200,406,0.99 [0.86-1.14],0.9159298041408692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,35263,335,0.80 [0.57-1.11],0.1863312128121504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,34891,335,1.17 [0.82-1.66],0.3938243504498463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,41698,408,1.17 [0.98-1.40],0.0884639618767432
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,34963,333,0.94 [0.80-1.12],0.5088230496176889
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,34824,331,0.81 [0.57-1.14],0.2287740816057961
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,34795,332,1.00 [0.83-1.20],0.995749535207874
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,34824,331,0.95 [0.79-1.14],0.5883328792691427
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,35870,341,1.01 [0.89-1.14],0.8806649194058032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,35082,331,1.00 [0.91-1.11],0.937714975686045
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,34963,333,0.89 [0.67-1.17],0.4006292310798407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,41125,401,1.14 [0.93-1.40],0.1973457380134611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,40363,400,1.00 [0.74-1.37],0.9816917367823214
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,40941,399,1.06 [0.93-1.21],0.4108743659897064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,35854,341,1.16 [0.92-1.47],0.2129867274930344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,41570,407,1.00 [0.92-1.09],0.933829554232288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,34974,334,0.98 [0.85-1.13],0.753222874928322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,34795,332,1.05 [0.80-1.37],0.7326919742863014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,40382,393,0.99 [0.81-1.22],0.9408918870538432
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,34963,333,1.00 [0.82-1.21],0.991472053016544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,35870,341,0.95 [0.86-1.05],0.3493312781262567
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,41192,405,1.15 [0.74-1.78],0.5369753243259218
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,41057,406,1.01 [0.87-1.18],0.8716566491259137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,35757,338,1.18 [0.91-1.52],0.21586816509777
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,35854,341,1.03 [0.93-1.13],0.5754173100916815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,40363,400,0.84 [0.71-1.01],0.0602408480762274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,34963,333,1.06 [0.82-1.36],0.6588782409452466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,40363,400,1.00 [0.88-1.13],0.9668919785007256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,40363,400,1.02 [0.90-1.16],0.7009257922952348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,41274,403,1.03 [0.90-1.17],0.6743528308962626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,41828,413,1.01 [0.91-1.11],0.9148039561872862
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,35263,335,1.02 [0.96-1.09],0.476846810522563
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,35854,341,1.01 [0.89-1.14],0.9222539116285736
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,41576,407,0.94 [0.81-1.08],0.359395089423551
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,34891,335,1.13 [0.96-1.33],0.1447087860975764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,34795,332,1.04 [0.85-1.29],0.6838831405917137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAT,Catalase,35405,334,0.81 [0.66-0.99],0.038485428547013
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,41269,407,1.02 [0.91-1.14],0.7937891307463678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,34824,331,0.91 [0.80-1.03],0.1493054748748912
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,41698,408,1.13 [0.87-1.47],0.3645148572957393
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,34974,334,1.00 [0.82-1.24],0.9725047121735548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,34795,332,0.89 [0.66-1.18],0.4128214137225554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,41018,400,0.94 [0.83-1.07],0.3592076361928438
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,35854,341,1.01 [0.84-1.21],0.932408661191882
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,35757,338,1.23 [1.01-1.51],0.0399169007863099
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,34963,333,0.99 [0.69-1.42],0.9687602358756264
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,35870,341,1.00 [0.88-1.15],0.9496231396389496
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,41323,407,1.12 [0.88-1.42],0.3461889779554984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,34974,334,1.02 [0.86-1.20],0.845830796391234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,41794,410,0.97 [0.77-1.23],0.8238549247404816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,41727,410,0.91 [0.80-1.03],0.1335992660516656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,41220,411,1.00 [0.80-1.25],0.9906468761646444
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,41828,413,1.46 [1.21-1.75],6.978963105691325e-05
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,41828,413,1.02 [0.86-1.21],0.7923162023429229
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,41230,404,0.99 [0.90-1.09],0.9127757572357644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,40752,406,0.95 [0.83-1.08],0.423750095055743
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,41689,410,1.01 [0.95-1.09],0.6928171376493849
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,40949,400,0.85 [0.71-1.01],0.0593641008988381
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,41794,410,1.01 [0.91-1.11],0.8753638999680428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,41484,405,1.13 [0.92-1.39],0.2430987056895415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,40879,403,1.02 [0.86-1.21],0.827883488727341
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,41484,405,1.04 [0.84-1.29],0.6995504435859032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,41423,404,0.96 [0.86-1.06],0.4012217910681956
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,41794,410,1.13 [0.95-1.35],0.1766090556632809
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,41274,403,0.98 [0.89-1.08],0.6393999838466713
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,41323,407,1.01 [0.87-1.17],0.912963732486706
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,41136,403,1.09 [0.94-1.26],0.2328298934030955
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,41274,403,1.00 [0.85-1.19],0.9595236819527024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,41358,405,0.93 [0.80-1.07],0.2861302350492167
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,41479,412,0.99 [0.91-1.08],0.9083339362768322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,41274,403,0.93 [0.79-1.09],0.3844945226963372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,41639,408,0.87 [0.76-1.00],0.057812418801763
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,41058,400,1.04 [0.92-1.17],0.5616979179639672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,41297,404,0.90 [0.77-1.06],0.2068204403803005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,41757,412,0.93 [0.71-1.21],0.5788035895801218
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,41698,408,1.01 [0.80-1.26],0.9448166733277912
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,41333,409,1.06 [0.85-1.34],0.5920009758054017
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,35263,335,0.97 [0.73-1.28],0.8126495139282756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,34891,335,1.04 [0.93-1.16],0.5383300580643771
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,41018,400,0.89 [0.73-1.07],0.2212167260925968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,40382,393,0.91 [0.74-1.12],0.3638678448989271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,35768,339,1.06 [0.83-1.34],0.658851276313597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,41333,409,0.98 [0.75-1.28],0.9007321789270124
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,40488,407,1.29 [1.05-1.60],0.017219065063622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,41794,410,1.08 [0.90-1.30],0.3898373409582248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,41479,412,1.01 [0.83-1.24],0.8932258957481445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,41333,409,1.36 [1.06-1.75],0.0167638091599206
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,34963,333,1.18 [0.90-1.55],0.2248866235944465
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,41271,408,1.01 [0.94-1.08],0.7773822374133357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,41438,410,0.89 [0.62-1.27],0.5121258896509941
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,34795,332,1.12 [0.88-1.43],0.3451377759585036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,41274,403,0.88 [0.63-1.24],0.4791008782594694
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,41140,403,1.08 [0.84-1.39],0.5292641418171459
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,40388,395,0.93 [0.74-1.17],0.5236034381081258
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,41421,410,1.02 [0.82-1.28],0.8505591579723345
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,41794,410,1.08 [0.88-1.34],0.4497471310708485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,34891,335,1.07 [0.84-1.38],0.5746140047879454
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,41794,410,0.98 [0.72-1.35],0.919230276488654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,35930,344,1.04 [0.81-1.35],0.738995416885817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,41438,410,1.09 [0.88-1.35],0.4412231715822028
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,41018,400,1.29 [1.00-1.67],0.049256642548656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,41283,403,1.13 [0.88-1.45],0.3523651652279757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,40382,393,1.08 [0.85-1.37],0.536882108333274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,41323,407,0.96 [0.84-1.11],0.5829075321659563
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,35152,331,1.08 [0.77-1.54],0.6476558359568645
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,41689,410,1.24 [0.97-1.59],0.0914088756660091
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,41565,408,1.07 [0.86-1.32],0.561444186405502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,41698,408,1.15 [0.98-1.34],0.0815835453172551
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,41333,409,0.90 [0.72-1.14],0.3903709266409793
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,41125,401,1.32 [0.99-1.75],0.0572459621529804
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,41438,410,0.96 [0.86-1.07],0.4227105715420298
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,41546,409,1.13 [0.79-1.63],0.5030507130547688
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,34891,335,1.22 [0.97-1.53],0.085234702083732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,41125,401,1.10 [0.84-1.45],0.4772397912862617
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,34824,331,0.78 [0.55-1.11],0.1668494412052127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,35263,335,1.05 [0.79-1.38],0.7361133096811032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,34891,335,0.94 [0.83-1.07],0.362640689362809
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,41200,403,1.04 [0.77-1.39],0.8155165736586493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,41297,404,1.01 [0.85-1.21],0.8821338706516043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,41794,410,0.98 [0.87-1.09],0.6642363976243946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,41083,409,1.04 [0.77-1.42],0.7884826941000497
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,41423,404,1.12 [0.83-1.50],0.4658388938307775
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,41639,408,1.29 [1.00-1.67],0.0488456330949636
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,39884,394,0.95 [0.68-1.34],0.7855768072372258
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,41213,401,1.00 [0.60-1.65],0.9918884879355409
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,39839,395,1.09 [0.74-1.61],0.6624858901325389
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,35792,343,1.01 [0.81-1.26],0.9312539721725333
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,41720,409,1.09 [0.92-1.29],0.30842419179893
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,40949,400,0.87 [0.74-1.04],0.129056162921386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,41134,407,1.00 [0.90-1.10],0.9273520330068628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,34824,334,1.13 [0.89-1.43],0.3199108778841365
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,41274,403,1.02 [0.83-1.26],0.8414247555924343
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,35152,331,1.21 [0.94-1.56],0.1330297133215947
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,41689,410,1.12 [0.87-1.45],0.3773826776450099
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,41794,410,1.08 [0.88-1.32],0.4540986885318439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,35921,340,1.29 [0.94-1.75],0.1093248312135989
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,35263,335,1.25 [1.01-1.55],0.0432514578989152
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,41274,403,1.05 [0.81-1.36],0.7250373236978923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,41274,403,0.96 [0.72-1.27],0.756817742797046
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,35768,339,0.96 [0.67-1.37],0.8202282161541257
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,41689,410,1.23 [1.04-1.45],0.0158142388437025
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,39757,392,1.06 [0.79-1.41],0.709040111467946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,41333,409,1.01 [0.65-1.58],0.9611421995438476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,41333,409,0.93 [0.65-1.34],0.7096356566997855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,35859,340,0.74 [0.58-0.93],0.0088432233918536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,35854,341,1.38 [0.94-2.02],0.1045073802048573
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,34667,329,1.10 [0.95-1.28],0.2019547655405373
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,34667,329,1.01 [0.78-1.32],0.9295245135012185
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,35701,338,1.00 [0.86-1.16],0.992159244553044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,40382,393,0.97 [0.83-1.12],0.6562648551873917
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,41438,410,0.98 [0.88-1.09],0.6974910732012412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,35768,339,1.00 [0.90-1.10],0.9478587418011282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,41018,400,1.05 [0.90-1.24],0.5367970133881711
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,39935,397,1.14 [0.92-1.42],0.2316428767013488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,41612,409,1.07 [0.94-1.22],0.2930635120429778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,41323,407,1.15 [1.02-1.30],0.0269748272876091
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,41323,407,1.09 [0.85-1.40],0.5118799010345212
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,35263,335,0.85 [0.58-1.25],0.4021370693739312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,35854,341,1.07 [0.73-1.58],0.7269179986923602
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,41689,410,1.18 [0.93-1.50],0.1683875682918763
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,34824,331,0.98 [0.78-1.23],0.83724870900873
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,41828,413,0.98 [0.73-1.31],0.8833705997943384
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,41323,407,0.97 [0.77-1.22],0.7661726385637954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,40363,400,0.99 [0.80-1.23],0.9451328782182744
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,41125,401,0.97 [0.85-1.10],0.6356166979722759
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,41323,407,1.05 [0.84-1.32],0.656854730981602
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,34667,329,1.24 [0.93-1.65],0.1513098470829696
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,35870,341,0.79 [0.65-0.96],0.0164432435954968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,34824,331,0.85 [0.68-1.06],0.1555389097254681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,41125,401,1.04 [0.96-1.13],0.3743053438595805
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,41125,401,0.97 [0.88-1.06],0.5018136915484797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,41125,401,0.95 [0.72-1.25],0.7001401675366543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,41356,404,1.05 [0.74-1.47],0.7976333241053751
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,41661,408,0.98 [0.80-1.20],0.8599140228164568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,41371,408,0.81 [0.53-1.23],0.3247654213454576
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,35768,339,0.99 [0.87-1.12],0.8484729266146847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,35263,335,1.10 [0.96-1.26],0.1601248276532909
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,35768,339,0.86 [0.66-1.12],0.2669976876184351
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,35263,335,1.07 [0.85-1.35],0.548365276434515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,41274,403,1.03 [0.93-1.14],0.5250515955485041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,40382,393,0.84 [0.69-1.03],0.1012013270963475
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39840,388,1.12 [0.97-1.28],0.124629239530363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,35930,344,0.96 [0.74-1.24],0.7437565692043681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40589,398,0.91 [0.76-1.09],0.3112881140338089
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,34891,335,1.31 [1.04-1.64],0.0205795734605306
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,40589,398,0.85 [0.67-1.09],0.2004944993193237
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,35930,344,0.98 [0.83-1.15],0.7830776898775529
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,41759,413,1.00 [0.87-1.16],0.9918189911155836
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,35152,331,0.80 [0.55-1.17],0.2522741865975065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,34891,335,1.10 [0.80-1.52],0.5450828648503949
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,34824,331,0.80 [0.64-1.00],0.0492884200086827
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,35263,335,0.87 [0.72-1.07],0.1844958785196802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,35263,335,1.03 [0.89-1.19],0.7215981860148213
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,34795,332,1.04 [0.83-1.30],0.7591667603683117
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,34667,329,1.06 [0.83-1.34],0.655320326683754
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,40581,397,0.93 [0.79-1.08],0.3475154052098201
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,34974,334,0.92 [0.80-1.07],0.2715128213656624
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,40382,393,1.01 [0.89-1.14],0.8974992303188174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,35263,335,0.93 [0.76-1.14],0.4972468764874169
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,34667,329,1.00 [0.75-1.33],0.9809494295750912
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,40272,397,0.96 [0.84-1.09],0.5505203192919466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,40382,393,0.98 [0.85-1.13],0.8104126806912557
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,40363,400,0.92 [0.79-1.06],0.2469373928466452
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,41414,409,1.03 [0.93-1.15],0.5572606973114174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,41125,401,0.91 [0.77-1.07],0.2560982880691991
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,41125,401,1.02 [0.90-1.15],0.7673640485687065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,40363,400,0.97 [0.85-1.11],0.6268489994339598
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,35768,339,0.99 [0.87-1.14],0.9021945512332612
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,35329,340,0.89 [0.65-1.23],0.4815987705230923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,40382,393,0.95 [0.77-1.16],0.5821731349340458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,35977,343,0.96 [0.58-1.59],0.889388450128273
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,33897,324,1.09 [0.69-1.74],0.7042535182350793
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,35719,341,0.86 [0.72-1.02],0.0762774618442303
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,35911,342,1.11 [0.96-1.28],0.1649196702489828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,35482,341,1.13 [0.87-1.46],0.3604568233501951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,35977,343,1.37 [0.81-2.31],0.2463203668745423
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFP,Properdin,35977,343,0.82 [0.50-1.34],0.4227791827616994
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,41333,409,1.13 [0.99-1.30],0.0623818121489065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,35947,342,1.09 [0.83-1.43],0.5491586776213349
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,34963,333,1.00 [0.77-1.31],0.9968111189069992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,41323,407,1.22 [1.00-1.50],0.0523182815158339
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,40382,393,0.88 [0.75-1.02],0.0966599400896512
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,35152,331,0.93 [0.75-1.15],0.4822303367427994
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",35854,341,1.28 [1.01-1.63],0.0411445694197848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,35757,338,1.39 [1.00-1.92],0.0490587903494142
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,40589,398,1.05 [0.80-1.37],0.7510336528675318
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,35930,344,1.12 [1.01-1.24],0.0392654305085024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,41547,409,0.93 [0.75-1.15],0.5131375499018678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,40419,402,1.03 [0.93-1.15],0.5300463329235152
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,41504,410,1.02 [0.96-1.08],0.4603410872973483
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,41414,411,0.81 [0.60-1.09],0.167942939949625
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,34963,333,0.98 [0.82-1.17],0.8139098530797979
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,41018,400,0.93 [0.83-1.03],0.1721138632331239
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,35921,340,0.94 [0.78-1.13],0.500871893358279
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,34824,331,0.87 [0.74-1.02],0.0921871269308031
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,41423,404,0.89 [0.67-1.18],0.4121529463043026
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,41323,407,1.04 [0.86-1.25],0.6992162188005062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,34963,333,0.89 [0.66-1.21],0.4584659780184721
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,41438,410,0.92 [0.79-1.06],0.2227448272744419
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,35930,344,1.04 [0.86-1.26],0.6655031067182374
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,35263,335,0.98 [0.77-1.24],0.8492530131573242
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,35768,339,0.96 [0.86-1.07],0.4417084042154523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,34963,333,0.85 [0.66-1.08],0.1750479205067793
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,41594,409,1.38 [1.03-1.84],0.0284602721546178
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,35930,344,1.04 [0.87-1.24],0.6555251173742873
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",41154,401,1.11 [0.97-1.27],0.1253363577086077
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,34667,329,1.01 [0.87-1.16],0.9125258035834766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,41258,406,0.95 [0.83-1.09],0.4969275133512915
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,41018,400,1.09 [0.85-1.40],0.489012697082573
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,41256,408,0.97 [0.81-1.16],0.7111847883476133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,34891,335,1.99 [1.30-3.04],0.0015848697793166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,41333,409,1.29 [0.99-1.68],0.0602537054267198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,40589,398,1.07 [0.82-1.39],0.6367978010155932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,41689,410,1.01 [0.92-1.11],0.8055588485829716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,34963,333,0.91 [0.73-1.14],0.4119917522588141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,35143,340,0.78 [0.47-1.28],0.3195724763580044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,41274,403,0.79 [0.62-1.01],0.0647584194099057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,41274,403,1.08 [0.89-1.29],0.4361811270777147
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,41274,403,0.94 [0.81-1.08],0.3773177911852456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,41274,403,1.17 [0.90-1.52],0.2398884990647249
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,35869,344,0.93 [0.75-1.15],0.5002590433211342
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,41196,407,0.95 [0.70-1.27],0.710025136658401
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,40382,393,1.13 [0.94-1.38],0.1969259844335809
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,41794,410,1.09 [0.94-1.28],0.2595257033556368
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,34963,333,1.02 [0.81-1.29],0.8544773608496096
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,34963,333,0.94 [0.67-1.32],0.7148936960395404
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,34667,329,1.07 [0.87-1.32],0.5119573290878441
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,41274,403,1.02 [0.95-1.11],0.5533706836159116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,41698,408,0.97 [0.64-1.46],0.8688032042570288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,34963,333,0.78 [0.57-1.09],0.1437115759136922
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40941,399,0.99 [0.90-1.08],0.7836014766070445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,41260,409,1.01 [0.90-1.14],0.8569085768679742
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,40286,399,1.06 [0.84-1.34],0.6028405131902526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,40363,400,0.92 [0.77-1.10],0.3447870424978733
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,41794,410,1.15 [0.93-1.42],0.2093309136498275
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,35854,341,1.41 [1.02-1.95],0.03753488190739
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,40589,398,0.90 [0.73-1.09],0.2725948583929765
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,35977,343,1.34 [1.03-1.73],0.0299241508331099
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,41255,404,1.07 [0.88-1.30],0.4955412685567305
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,35921,340,0.98 [0.87-1.10],0.7118220437037366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,35757,338,1.01 [0.90-1.15],0.8210111229370483
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,41479,412,0.91 [0.75-1.09],0.3034298058358059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,34824,331,0.91 [0.73-1.13],0.3837418262383973
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",34908,333,0.94 [0.82-1.07],0.341044942707107
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,40589,398,0.92 [0.79-1.08],0.3085847038848729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,41125,401,0.98 [0.88-1.11],0.7906770580038784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNST,Consortin,41323,407,1.00 [0.92-1.09],0.9751145022418108
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,34824,331,0.96 [0.70-1.30],0.770573511487738
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,41828,413,0.95 [0.69-1.30],0.7428839419185418
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,41698,408,1.08 [0.89-1.31],0.4315642883802637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,41333,409,1.20 [0.89-1.62],0.2257574014622875
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,41333,409,1.07 [0.74-1.55],0.7058783708576597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,41422,406,0.90 [0.71-1.15],0.3985875048945927
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,41274,403,1.06 [0.86-1.31],0.5966017179563383
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,34963,333,1.04 [0.95-1.15],0.4070928341264518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,35921,340,1.09 [0.87-1.36],0.4556346240019899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,35930,344,0.92 [0.62-1.35],0.6710474919981843
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,41495,411,1.22 [0.84-1.77],0.2892265220254376
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,41828,413,0.97 [0.68-1.38],0.8587488026460939
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,35768,339,0.97 [0.81-1.16],0.7302948391633088
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,34963,333,0.97 [0.84-1.11],0.6446813036139803
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,34974,334,1.01 [0.88-1.15],0.9375787584988804
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,35930,344,1.60 [1.03-2.46],0.0345430028751898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,41323,407,1.17 [0.94-1.46],0.1693683331381037
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,35203,335,1.05 [0.86-1.28],0.6355636540058374
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,35152,331,1.35 [1.04-1.74],0.0227810632158494
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,41828,413,1.19 [0.94-1.52],0.1477276919642304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,41274,403,1.05 [0.87-1.26],0.6351033186899081
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,35263,335,1.07 [0.85-1.33],0.5727953106074674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,41283,403,1.34 [0.96-1.85],0.0835728375117073
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,34974,334,0.93 [0.78-1.11],0.4092390728707481
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,35757,338,0.91 [0.70-1.20],0.5149735984507164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,40885,405,0.90 [0.69-1.18],0.4556520429090523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,40149,390,1.00 [0.90-1.11],0.9929035565868674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',34795,332,1.11 [0.88-1.40],0.3777938360023023
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,40363,400,0.87 [0.71-1.07],0.1918125914551623
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",34974,334,0.88 [0.67-1.14],0.3216061243759062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,40467,397,0.99 [0.90-1.10],0.8649361191511903
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,34824,331,0.99 [0.75-1.33],0.9674630777280756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",41125,401,0.97 [0.85-1.10],0.6048661354832554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,35921,340,1.07 [0.78-1.47],0.6619363602703636
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,41828,413,1.05 [0.92-1.20],0.4943288962930686
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,41547,407,1.10 [0.97-1.25],0.1558661245615955
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,34457,326,0.99 [0.77-1.27],0.9157957794116954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,41828,413,1.04 [0.90-1.20],0.5693414748607826
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,35908,343,1.10 [0.69-1.74],0.6869660438759141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,41374,406,0.95 [0.76-1.19],0.6654875738148232
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,34667,329,1.20 [0.91-1.60],0.194422775687697
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,41494,408,1.33 [1.03-1.72],0.0275275099563897
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",34891,335,1.42 [1.00-2.02],0.0474183077305322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,41689,410,1.06 [0.93-1.21],0.4051127887394874
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,35860,343,1.04 [0.77-1.39],0.8013312098171325
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,34795,332,0.85 [0.64-1.13],0.2635384099504094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,41634,407,1.15 [0.93-1.43],0.1980592010669249
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,41438,410,1.01 [0.89-1.15],0.8376003013411599
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,35921,340,1.20 [0.81-1.79],0.3633858819464507
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,35810,342,1.01 [0.75-1.36],0.9445299349814396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,41479,412,1.13 [0.94-1.36],0.2063893445692535
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,40382,393,0.99 [0.89-1.10],0.8050319297428649
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,40941,399,0.93 [0.83-1.05],0.2373164914936115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,34667,329,1.13 [0.95-1.35],0.1801056267730681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,34667,329,1.15 [0.78-1.71],0.477192474328994
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,40780,404,0.84 [0.67-1.06],0.1339347385105319
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,35152,331,1.10 [0.82-1.46],0.5196919811542413
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,41423,404,1.16 [0.98-1.37],0.083219879792777
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,40314,392,0.87 [0.78-0.97],0.0106249710627978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,41283,403,1.27 [0.92-1.76],0.1453168367080992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,40589,398,1.04 [0.91-1.20],0.5438860275571956
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,41484,405,1.41 [0.91-2.17],0.124657383549833
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,41018,400,0.99 [0.78-1.26],0.9558311463107032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,41698,408,0.89 [0.77-1.04],0.1457330245879401
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,35607,336,0.53 [0.37-0.78],0.0010525445764488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,41353,402,1.01 [0.93-1.10],0.854487669059109
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,41484,405,1.08 [0.76-1.54],0.6543326282892292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,40150,395,1.07 [0.94-1.22],0.2993460924291483
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,41828,413,0.97 [0.73-1.29],0.8281723273174726
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,41018,400,1.07 [0.89-1.27],0.4734157307100173
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,34963,333,0.90 [0.72-1.14],0.3875979359024037
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,40589,398,1.03 [0.95-1.12],0.4327825356321989
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,35921,340,1.00 [0.85-1.17],0.95514668267211
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,35854,341,0.94 [0.80-1.09],0.3874928533314393
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,35854,341,0.99 [0.89-1.11],0.895877467847065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,34824,331,1.03 [0.89-1.18],0.6983821194072322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,34974,334,0.95 [0.84-1.06],0.3485315425833175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,34795,332,0.99 [0.91-1.09],0.8989299506768685
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,41484,405,1.40 [1.02-1.94],0.0389874003664836
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,35947,342,1.00 [0.77-1.30],0.981109457320613
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,34795,332,1.22 [0.93-1.62],0.1502752341361993
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,41018,400,0.98 [0.85-1.14],0.816766335838969
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,34891,335,1.12 [0.87-1.43],0.3847965540261445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,40581,397,1.08 [0.90-1.30],0.4009658802877054
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,34891,335,1.19 [0.84-1.70],0.3202974780681603
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,35947,342,1.12 [0.79-1.59],0.5100095708689919
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,34891,335,0.94 [0.79-1.12],0.5085464425963837
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,35870,341,0.89 [0.71-1.12],0.3258503598388435
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,35930,344,1.00 [0.73-1.37],0.9816474040418568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,34824,331,0.80 [0.64-1.02],0.0708262194636066
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,34795,332,1.15 [1.05-1.27],0.0035340554770938
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,31172,286,1.00 [0.90-1.12],0.9589208995948948
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,41410,411,1.17 [0.87-1.59],0.2986459216904229
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,40553,396,0.90 [0.76-1.05],0.1831830848283747
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,40271,402,0.98 [0.82-1.18],0.8530195248363062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,41358,405,1.06 [0.97-1.16],0.17614829573556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,40761,407,1.04 [0.85-1.28],0.6813610131035426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,35193,335,1.19 [0.97-1.44],0.0917996654693145
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,35427,337,0.92 [0.62-1.37],0.6950394035507204
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,40589,398,0.96 [0.87-1.07],0.5085582014078414
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,35930,344,1.10 [0.76-1.57],0.6200867721015657
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,35930,344,1.06 [0.77-1.47],0.7170808157249007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,34824,331,1.07 [0.81-1.43],0.6280759748941223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,41333,409,1.13 [0.97-1.32],0.1045694545332698
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,41292,403,1.05 [0.92-1.20],0.4979116288189302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,35854,341,1.05 [0.91-1.22],0.4782465393782061
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,41350,410,0.94 [0.80-1.11],0.4645856362321616
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,41214,403,0.93 [0.76-1.14],0.4782765424473157
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,38596,377,1.01 [0.81-1.26],0.9260765173640396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,35152,331,1.05 [0.86-1.29],0.6291638765354814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,41438,410,0.93 [0.75-1.16],0.513467387051749
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,40465,398,1.02 [0.91-1.15],0.6998870352262194
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,41323,407,1.32 [0.93-1.88],0.1250455462154311
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,41794,410,1.51 [1.16-1.98],0.0025923285584022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,32524,321,1.19 [0.75-1.87],0.4635698973147196
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,41568,406,0.93 [0.75-1.16],0.5338506553260196
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,41339,409,1.04 [0.79-1.37],0.7672275202047476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,34963,333,0.83 [0.61-1.13],0.2405110786065079
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,35556,336,0.97 [0.81-1.15],0.7147902594842597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,41018,400,0.99 [0.76-1.29],0.9365112783382172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,41274,403,1.13 [0.95-1.35],0.1531178288850455
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,41231,405,1.07 [0.98-1.17],0.1328559718292113
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,41484,405,1.05 [0.92-1.20],0.4929684454747524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,41689,410,0.93 [0.83-1.05],0.2302117805688707
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,40581,397,0.88 [0.70-1.10],0.2589657615103679
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,41689,410,1.06 [0.92-1.22],0.450393429040153
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,40581,397,1.04 [0.89-1.22],0.595313546135429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,41758,413,1.08 [0.74-1.57],0.6869500037139027
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,41794,410,1.21 [0.99-1.47],0.0638387735247198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,41297,404,1.04 [0.95-1.15],0.3570941378941857
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,41186,405,1.04 [0.97-1.13],0.2817237122882131
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,41794,410,1.04 [0.93-1.17],0.4905808458348426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,41039,404,0.98 [0.86-1.11],0.7458443354629295
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,41484,405,1.04 [0.91-1.19],0.527733234670497
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,34667,329,0.92 [0.78-1.08],0.2933743312587125
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,35361,338,1.10 [0.91-1.33],0.3106589106708087
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",34795,332,0.99 [0.88-1.12],0.8896750040547939
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,34667,329,0.97 [0.84-1.13],0.698366506571529
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,35930,344,0.81 [0.53-1.23],0.3189368774119289
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,35152,331,0.97 [0.85-1.11],0.6670115362072568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,41698,408,0.98 [0.91-1.06],0.6341093945177074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,41484,405,1.04 [0.86-1.26],0.6710814715889843
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,34891,335,1.09 [0.91-1.31],0.3310398794240997
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,34891,335,1.05 [0.88-1.26],0.5632311183753387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,41274,403,0.99 [0.92-1.06],0.7010060042776252
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",40941,399,0.95 [0.84-1.07],0.4034536465489753
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,35885,342,0.98 [0.90-1.07],0.6823533992463163
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,41145,407,0.99 [0.89-1.11],0.9227365165988256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,34891,335,1.12 [0.91-1.37],0.2989926504614714
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,41484,405,0.99 [0.90-1.09],0.8587364767589067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",41438,410,1.07 [0.84-1.37],0.5836575321621094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,34963,333,1.01 [0.63-1.61],0.9621799797694752
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,34667,329,1.03 [0.87-1.22],0.6983753035322661
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,34667,329,1.25 [0.90-1.73],0.1768293600831514
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCN,Decorin,40589,398,1.03 [0.70-1.51],0.8792116482605348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,35152,331,1.00 [0.90-1.12],0.9671624948392712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,41698,408,0.94 [0.82-1.07],0.3525477890863996
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,41125,401,0.97 [0.88-1.06],0.487941580972326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,40363,400,0.98 [0.87-1.11],0.7713811909262307
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,41323,407,1.27 [0.95-1.68],0.1015830853733919
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,34824,331,0.94 [0.81-1.09],0.4167364267561225
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,34667,329,0.96 [0.84-1.10],0.5897334273532644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,41438,410,0.90 [0.76-1.06],0.208630629227201
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,34795,332,1.17 [0.92-1.49],0.2030045557889642
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",41125,401,1.14 [0.94-1.39],0.1794281060060314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,41269,407,1.09 [0.91-1.31],0.3672880233671582
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,35870,341,0.98 [0.83-1.14],0.7560630684766871
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,35152,331,0.88 [0.77-1.01],0.0735193894856267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,41689,410,1.14 [0.78-1.66],0.5126267288183449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,35930,344,0.82 [0.63-1.06],0.1230641636150514
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,35768,339,0.91 [0.73-1.14],0.4325879241817368
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,34963,333,0.97 [0.73-1.30],0.8511593494363255
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,34891,335,1.35 [0.93-1.97],0.1132779070975801
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,34891,335,1.08 [0.90-1.30],0.4012045226635043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,34963,333,1.08 [0.81-1.43],0.5950941138600201
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,40382,393,1.02 [0.87-1.20],0.7781600375458539
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",41274,403,1.00 [0.91-1.09],0.955723026297466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,40499,404,0.89 [0.75-1.06],0.2017580509638985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,34629,332,0.94 [0.72-1.22],0.6318274277961706
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,34824,331,0.82 [0.66-1.01],0.0652761101448621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,34824,331,0.90 [0.77-1.06],0.1989734644111577
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,34824,331,1.00 [0.83-1.21],0.9882193256017656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,40723,399,0.99 [0.93-1.05],0.6605154606816198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,34795,332,1.00 [0.81-1.24],0.9921775092185766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,34891,335,1.00 [0.83-1.20],0.9750152209730232
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,41794,410,0.97 [0.85-1.11],0.6373232299513056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,34824,331,0.98 [0.76-1.26],0.8850262016117908
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,34891,335,1.10 [0.91-1.34],0.3077191704617372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,40581,397,0.88 [0.68-1.14],0.320590161698597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,34795,332,1.07 [0.87-1.33],0.5171528255517567
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,35757,338,1.01 [0.78-1.30],0.9523569566578256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,35854,341,1.09 [0.88-1.35],0.4255453921291772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",41196,407,1.00 [0.92-1.08],0.9047613953011656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,34963,333,0.85 [0.65-1.12],0.245290163001702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,35152,331,0.88 [0.60-1.30],0.5305872994286218
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,41689,410,0.99 [0.85-1.14],0.8693193243714077
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,41828,413,1.14 [0.85-1.53],0.3832630090290007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,40952,398,0.97 [0.80-1.18],0.7598911837760929
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,41125,401,1.05 [0.94-1.16],0.391634625556888
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,35854,341,1.01 [0.87-1.16],0.92884641875344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,35870,341,1.02 [0.83-1.24],0.8625141296664909
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,41828,413,1.15 [0.98-1.34],0.0843148641756941
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,41438,410,1.04 [0.78-1.40],0.7808430356052587
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,34974,334,0.99 [0.88-1.11],0.8251326665341835
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,34974,334,1.18 [0.97-1.44],0.0993814044837349
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,34974,334,0.98 [0.81-1.17],0.7936809476938644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,34667,329,1.04 [0.83-1.31],0.7085155339973872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,41668,410,0.97 [0.87-1.08],0.5592809256545417
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,35854,341,0.83 [0.72-0.97],0.0154327891880163
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,41125,401,0.93 [0.84-1.03],0.16849017507317
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,35768,339,1.02 [0.87-1.20],0.7718426226232149
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,35152,331,0.85 [0.69-1.04],0.1196311721822312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,34818,330,0.99 [0.87-1.12],0.8590009448783916
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,40589,398,0.96 [0.82-1.13],0.641939836760109
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,35854,341,1.08 [0.83-1.41],0.5596156888836153
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,34974,334,0.97 [0.85-1.10],0.6275638341566624
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,35768,339,0.95 [0.83-1.09],0.482482828284104
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,41222,403,1.04 [0.73-1.46],0.8412743040856223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,34824,331,0.95 [0.84-1.08],0.4605044612093617
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,35768,339,0.94 [0.86-1.03],0.2073515639895364
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,35870,341,0.93 [0.76-1.13],0.4522937639477979
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,41018,400,0.97 [0.83-1.13],0.6844986900764909
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,35854,341,1.06 [0.88-1.28],0.5299211300844141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,41414,403,0.89 [0.75-1.06],0.183908918096874
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,34963,333,0.69 [0.48-0.98],0.0375824529902604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,34824,331,0.96 [0.87-1.05],0.3787377453374962
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,35854,341,0.99 [0.92-1.07],0.856935788662282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,41323,407,1.01 [0.94-1.09],0.7680627886733149
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,40941,399,1.02 [0.84-1.22],0.8596176847626005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,41125,401,0.80 [0.60-1.09],0.1558552233534362
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,41274,403,1.19 [0.93-1.51],0.1600332963124529
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,40557,405,0.88 [0.64-1.21],0.4192338957314091
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,41125,401,0.98 [0.76-1.27],0.8726788404499345
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,40995,406,1.00 [0.87-1.16],0.9640063987751032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,41828,413,1.16 [0.82-1.65],0.3895841424652552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,41573,407,1.01 [0.87-1.17],0.937870965684914
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,41018,400,1.01 [0.82-1.24],0.9558661913382132
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,41125,401,1.01 [0.86-1.18],0.9395031381518004
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,40850,400,1.22 [0.95-1.57],0.1236532855063427
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,35870,341,1.20 [0.90-1.61],0.2042881499960228
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,41333,409,0.79 [0.57-1.09],0.1556224413085201
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,41571,408,1.00 [0.78-1.29],0.980735235889138
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,40980,401,0.94 [0.78-1.12],0.4882563541021788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,35152,331,0.99 [0.87-1.11],0.8109703311880762
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,35690,337,1.30 [1.03-1.63],0.0283569531806808
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,34963,333,0.97 [0.81-1.16],0.7400974616135616
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,41125,401,1.00 [0.69-1.46],0.9957428149290064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,35921,340,0.93 [0.80-1.08],0.3450960049095134
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,40589,398,1.08 [0.96-1.21],0.2132327054368421
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,35757,338,1.02 [0.80-1.31],0.8722607508862574
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,34963,333,0.98 [0.84-1.16],0.8378621126071778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,40363,400,0.99 [0.90-1.10],0.8791622332449741
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",35768,339,0.96 [0.87-1.06],0.3879641048678188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,35854,341,0.94 [0.75-1.18],0.602345902618616
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,35757,338,1.09 [0.89-1.34],0.4167958867032749
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,34963,333,0.97 [0.85-1.11],0.6746289425179792
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,35757,338,1.16 [0.91-1.46],0.226209565012502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,41018,400,0.98 [0.90-1.08],0.7423585714410542
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,41635,407,1.07 [0.80-1.43],0.6486955420271995
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,40363,400,1.02 [0.80-1.30],0.8832802899514238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",35921,340,1.02 [0.88-1.17],0.8030212880974978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",34974,334,0.97 [0.87-1.08],0.5983571809903313
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,34795,332,1.06 [0.90-1.26],0.4657394203861094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,34988,337,0.92 [0.69-1.21],0.5355260781820127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,34824,331,0.98 [0.79-1.20],0.8218416325020437
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,41698,408,1.26 [1.00-1.57],0.0475506842396474
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,41274,403,0.92 [0.83-1.01],0.0785984052496695
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,35757,338,0.94 [0.78-1.14],0.5433195097452017
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,34795,332,0.89 [0.66-1.21],0.4604390617842466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,35870,341,1.06 [0.91-1.22],0.460909267921027
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40589,398,1.19 [0.93-1.53],0.1731312003002931
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,34974,334,1.34 [0.94-1.91],0.1111712378714869
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,34891,335,1.16 [0.94-1.44],0.1639110681104753
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,35921,340,1.00 [0.89-1.12],0.9380475845112922
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,35768,339,1.09 [0.77-1.55],0.6321767543881198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,35263,335,1.00 [0.74-1.35],0.9761607501463048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,41410,412,0.97 [0.73-1.28],0.8274527297761687
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,35870,341,1.07 [0.80-1.43],0.6578518372011642
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,41268,409,1.28 [0.95-1.73],0.1008294611973187
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,40949,400,1.44 [1.09-1.91],0.0098176222933514
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,34963,333,1.01 [0.84-1.22],0.9212830297719472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,41233,403,1.00 [0.92-1.09],0.9565190941549364
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,40382,393,0.82 [0.65-1.04],0.1078608033164459
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,35768,339,1.11 [0.80-1.55],0.5312591633067719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,41828,413,0.61 [0.35-1.03],0.0662488464636938
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,41274,403,0.94 [0.80-1.12],0.4919192445545695
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,35921,340,0.99 [0.86-1.14],0.9141003001962124
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,34974,334,0.97 [0.89-1.06],0.5623196442113381
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",35854,341,1.04 [0.87-1.25],0.6363632028229302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",35642,337,1.00 [0.91-1.10],0.9917212357613944
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,34795,332,1.02 [0.87-1.20],0.7779787482427647
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,34974,334,1.01 [0.79-1.30],0.9237831847945994
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,41018,400,0.88 [0.75-1.02],0.0992774048370469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,34891,335,0.99 [0.88-1.11],0.8312313052131266
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,41323,407,0.93 [0.81-1.07],0.2981858703227603
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,41794,410,0.98 [0.90-1.08],0.7368038383948452
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,35870,341,0.98 [0.84-1.15],0.8041198288011409
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,34795,332,0.98 [0.77-1.26],0.883524731244447
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,40581,397,1.03 [0.76-1.39],0.843186388422737
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,35870,341,0.98 [0.87-1.11],0.7525180473769315
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,34824,331,0.95 [0.83-1.08],0.427006558519741
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELN,Elastin,35921,340,0.88 [0.65-1.19],0.406221986847048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,41125,401,0.89 [0.75-1.07],0.2144020143948641
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,34795,332,1.04 [0.79-1.36],0.7887547986728499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,40581,397,1.06 [0.88-1.27],0.5539557934588063
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,33168,321,1.03 [0.84-1.25],0.7872968213807491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,41828,413,1.53 [0.93-2.52],0.0977525204990923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,41273,406,0.99 [0.89-1.11],0.8945315276455479
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,41689,410,0.96 [0.84-1.10],0.5271870864114845
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,34974,334,1.03 [0.86-1.22],0.7675177868178336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,35757,338,0.92 [0.75-1.14],0.4609581475465655
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,34795,332,0.90 [0.61-1.33],0.6008234557299945
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,34795,332,0.63 [0.45-0.87],0.0051003745976244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,41828,413,0.92 [0.66-1.29],0.6405933752891035
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,41484,405,1.10 [0.89-1.37],0.3694072866213708
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,34974,334,0.94 [0.70-1.25],0.6568127525793588
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,40029,389,1.07 [0.96-1.19],0.23119836621876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,35757,338,0.84 [0.68-1.04],0.1157841889679271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,40382,393,0.92 [0.75-1.14],0.448188272209846
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40589,398,1.01 [0.67-1.52],0.9746168892013476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40589,398,1.19 [0.85-1.66],0.3104599219402439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,34974,334,0.87 [0.72-1.06],0.1669178721932875
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,34891,335,1.16 [0.85-1.58],0.3598800729762926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,34963,333,0.94 [0.78-1.12],0.4696950992194205
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,41282,403,1.02 [0.93-1.12],0.6630443687408596
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,35757,338,0.77 [0.58-1.03],0.0823453634368084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,41414,403,1.06 [0.81-1.40],0.6565273323385394
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,40363,400,0.99 [0.87-1.14],0.8950965968396405
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,39854,383,1.23 [0.93-1.64],0.1510273078132629
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,35152,331,1.02 [0.71-1.47],0.9205175175717067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,41828,413,1.42 [1.01-1.99],0.0409533739186358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,40941,399,1.08 [0.82-1.42],0.6015806139434552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,40589,398,0.94 [0.81-1.10],0.4480186209080785
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,35263,335,1.03 [0.82-1.31],0.7799108333328928
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,41274,403,1.13 [1.01-1.27],0.0352584403845065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,34974,334,1.03 [0.89-1.20],0.6553836954714163
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,41636,408,1.32 [0.99-1.75],0.0591078481395099
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,41438,410,0.86 [0.60-1.23],0.4124972606798931
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,41160,402,1.10 [0.70-1.72],0.6841622727309495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,41438,410,0.91 [0.63-1.31],0.6119009667348041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,41125,401,1.00 [0.92-1.09],0.9755133656307678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,34963,333,1.03 [0.90-1.17],0.701210483986251
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,34667,329,1.15 [0.87-1.50],0.3247305286499932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,40941,399,0.98 [0.88-1.10],0.7666826682065001
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,35263,335,1.05 [0.78-1.43],0.7382554147929397
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,34891,335,1.09 [0.86-1.38],0.4925031200535569
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,35757,338,1.15 [0.87-1.51],0.3229331083426054
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,35152,331,0.99 [0.91-1.09],0.8648107360590611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,41058,400,0.95 [0.67-1.34],0.7765759833807508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,34795,332,1.27 [1.03-1.57],0.0281200471959553
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,41828,413,1.06 [0.81-1.39],0.6544025135738392
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,41283,403,0.76 [0.58-0.98],0.0359925319267446
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,34667,329,0.94 [0.77-1.15],0.5651396598976922
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,34891,335,1.02 [0.85-1.23],0.8035090014574306
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,35854,341,0.96 [0.84-1.09],0.4997786194938318
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,34667,329,0.88 [0.66-1.17],0.3693357333183714
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,34891,335,1.03 [0.92-1.16],0.6273665696807598
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,35263,335,0.99 [0.72-1.37],0.9669724132805684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,34795,332,0.98 [0.81-1.18],0.8273072117772732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,34795,332,0.98 [0.79-1.23],0.8704411211144298
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,41689,410,1.10 [0.76-1.58],0.614971735710048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,35947,342,0.92 [0.64-1.33],0.6635331706320097
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,35464,342,0.99 [0.71-1.39],0.958145542901678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,41333,409,0.93 [0.79-1.09],0.3471402219847485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,35977,343,1.10 [0.85-1.41],0.4802635626134673
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,35792,343,1.01 [0.67-1.52],0.9482389416815712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,35977,343,1.00 [0.50-1.98],0.9942373707568268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,41423,404,1.04 [0.89-1.22],0.5858357625552559
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,41442,407,1.11 [0.80-1.55],0.5318207804294519
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,41421,412,1.02 [0.77-1.35],0.908919730873256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,41419,411,1.53 [0.95-2.46],0.0800753256593941
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",41283,403,1.04 [0.95-1.14],0.3858133467678341
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",41323,407,1.04 [0.94-1.16],0.4557709427482007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",35921,340,1.28 [1.06-1.54],0.0105243926287226
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",41828,413,1.09 [0.91-1.29],0.3481600956373091
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,41561,409,1.03 [0.90-1.17],0.6641422836084797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,40526,398,1.08 [0.93-1.25],0.3224840136342414
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,41274,403,1.02 [0.87-1.19],0.8004247749826667
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,41323,407,0.98 [0.88-1.10],0.7787532779794635
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,35768,339,0.94 [0.81-1.11],0.4752996472263171
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,35870,341,1.03 [0.96-1.10],0.4119552859462361
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,35757,338,0.98 [0.67-1.44],0.933296986658857
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,34974,334,0.90 [0.76-1.08],0.2617716738260804
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,35921,340,1.12 [0.78-1.62],0.5324659486321048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,41125,401,1.19 [0.92-1.55],0.184750016770599
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,41269,407,1.10 [0.82-1.47],0.5184068271313813
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,35768,339,1.07 [0.95-1.21],0.2796679742219327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,41828,413,0.84 [0.61-1.15],0.2735173954159359
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,34963,333,1.08 [0.94-1.25],0.2929487737388048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,41700,413,1.13 [0.88-1.44],0.3413505117114322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,41794,410,0.86 [0.68-1.09],0.200742771325707
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,35930,344,1.03 [0.73-1.44],0.8781617959941793
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,34963,333,1.07 [0.89-1.28],0.4728023718428328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",41323,407,1.05 [0.93-1.18],0.4122176013509133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,35921,340,1.05 [0.90-1.21],0.5508820439155907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,41274,403,0.87 [0.72-1.05],0.147477093713792
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,35870,341,1.18 [0.77-1.82],0.450156717240382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,41333,409,0.98 [0.82-1.18],0.8516351040834401
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,41156,410,1.03 [0.89-1.19],0.7165502466482008
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,40382,393,0.94 [0.80-1.11],0.4724987080771932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,41355,412,0.94 [0.79-1.12],0.4997663216144262
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,35885,342,0.99 [0.83-1.19],0.9152168597042812
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,41136,406,1.08 [0.87-1.35],0.481173636968041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,41323,407,1.10 [0.90-1.35],0.3309090947212418
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,41601,408,1.08 [0.90-1.30],0.3876173275823045
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,40581,397,1.12 [0.95-1.32],0.1730181022763989
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,41333,409,0.95 [0.82-1.11],0.5338177888535659
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,41274,403,1.04 [0.91-1.18],0.5772627184506363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,40382,393,0.95 [0.81-1.10],0.4961808560236713
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",34795,332,0.90 [0.75-1.08],0.2440538983056084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",34795,332,1.09 [0.91-1.30],0.3574238196189179
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,40382,393,0.93 [0.80-1.08],0.339531463286171
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,40382,393,0.82 [0.67-1.00],0.0539006519633416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,41419,411,0.95 [0.73-1.24],0.6954162881077588
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,35140,338,1.10 [0.78-1.55],0.5886493324676285
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",35870,341,1.01 [0.88-1.14],0.9355428369389353
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,34891,335,1.20 [1.02-1.42],0.0254891618588484
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,34891,335,0.99 [0.78-1.24],0.9050283639578296
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,41484,405,1.10 [0.98-1.23],0.1116334299720523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,41274,403,1.00 [0.88-1.14],0.9844446762228646
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,34891,335,1.11 [0.89-1.37],0.3607273150371202
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,41635,407,1.02 [0.95-1.10],0.6134402145778499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,41636,408,1.09 [0.94-1.28],0.2538144100227801
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,34891,335,0.94 [0.66-1.35],0.7431664830690665
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,40581,397,1.28 [0.99-1.66],0.0643503391112049
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,34891,335,1.09 [0.85-1.38],0.509061801948786
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,34667,329,0.92 [0.80-1.07],0.2961244999624672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,34602,329,0.80 [0.62-1.03],0.0810817225282162
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,41438,410,0.77 [0.59-1.00],0.0485587794849708
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,35930,344,0.91 [0.74-1.11],0.3554878134608693
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,35854,341,1.04 [0.79-1.38],0.7737116606256118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,41438,410,1.19 [0.80-1.76],0.3934390028242466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,35152,331,1.06 [0.87-1.30],0.5446289823785524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,35947,342,1.12 [0.96-1.32],0.1545547427953408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,40363,400,0.91 [0.78-1.07],0.2678424275374038
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",34824,331,1.01 [0.89-1.14],0.9267949304719408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,34795,332,0.96 [0.77-1.21],0.7452154282514807
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,40363,400,0.92 [0.81-1.04],0.1640545246199247
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,41288,403,0.99 [0.88-1.11],0.8777205395160222
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,35870,341,1.00 [0.90-1.11],0.9790121019328348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,41459,407,0.94 [0.87-1.02],0.1352914190175582
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,41018,400,0.91 [0.74-1.12],0.3744159295431298
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,41018,400,0.97 [0.88-1.07],0.5537175741686098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,40286,399,0.96 [0.79-1.17],0.6699609187700082
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,35768,339,0.92 [0.77-1.10],0.3568059023567017
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,40382,393,0.99 [0.91-1.07],0.7740619666873997
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,41018,400,1.24 [0.91-1.69],0.1743519887395276
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,41048,401,0.66 [0.43-1.02],0.0622994363953313
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,40382,393,0.74 [0.54-1.01],0.0612214238894404
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,41794,410,1.31 [1.02-1.69],0.0360938862331381
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,41438,410,0.95 [0.74-1.23],0.7197757410640331
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,40363,400,0.94 [0.81-1.08],0.3729901180284463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,40382,393,1.02 [0.79-1.31],0.895847157428364
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,35977,343,1.04 [0.71-1.53],0.8331574991283212
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,35854,341,1.02 [0.82-1.28],0.8475200427182394
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,35757,338,0.98 [0.73-1.33],0.909961153179657
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,34891,335,1.04 [0.94-1.14],0.4777116756515448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,41246,407,0.93 [0.69-1.27],0.6648661093046253
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,41689,410,1.42 [1.06-1.91],0.0191210239616065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,41306,407,1.03 [0.99-1.08],0.1751432915739046
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,34602,329,1.03 [0.77-1.39],0.8327519961189136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,40363,400,1.10 [0.89-1.37],0.3704176904086733
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,34891,335,1.12 [0.89-1.40],0.3267182569427573
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,41274,403,1.03 [0.93-1.14],0.6257857853740125
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,40382,393,1.03 [0.94-1.13],0.565562152389123
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,34795,332,0.97 [0.83-1.14],0.7455978270901062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,34963,333,0.67 [0.49-0.90],0.0085221620632348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,40886,399,0.69 [0.49-0.98],0.037073439246111
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,34974,334,1.25 [1.03-1.51],0.021700005562115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FST,Follistatin,41423,404,0.87 [0.72-1.04],0.1351601173712351
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,34974,334,1.38 [0.87-2.20],0.1723892407063946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,41219,402,1.10 [0.83-1.46],0.5022013580976411
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,35787,340,1.01 [0.90-1.15],0.8256978256799515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,41570,411,0.94 [0.85-1.04],0.2664425177564165
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,35152,331,0.94 [0.79-1.12],0.4843585655218785
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FURIN,Furin,41438,410,1.02 [0.78-1.33],0.8924954190547265
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,40321,393,0.96 [0.76-1.21],0.7108597314922263
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",35192,334,1.19 [1.02-1.37],0.0218822836225097
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,41689,410,1.19 [0.99-1.44],0.068515531366118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",41018,400,0.96 [0.83-1.12],0.6154194490918719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",41698,408,0.94 [0.83-1.06],0.2840239450566267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,40581,397,1.04 [0.90-1.19],0.6123590130980545
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,41260,409,0.98 [0.89-1.07],0.630225903352921
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,34963,333,0.83 [0.67-1.03],0.08709036601316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,34824,331,1.06 [0.84-1.34],0.5984264724539785
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,35757,338,1.07 [0.87-1.32],0.5288976166409816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,35263,335,1.07 [0.92-1.24],0.3786487066108661
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,34824,331,0.84 [0.69-1.02],0.0720636275094025
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,34667,329,0.96 [0.64-1.44],0.8325898630528124
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,34891,335,1.09 [0.89-1.34],0.4247258595116784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,35263,335,0.99 [0.80-1.23],0.9348411884443146
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,34974,334,0.92 [0.75-1.13],0.447483615589562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,34667,329,1.10 [0.94-1.27],0.2260897409966775
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,41484,405,0.95 [0.83-1.09],0.5012606328230242
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,41125,401,1.20 [0.87-1.65],0.2666554301800065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,41698,408,1.15 [0.83-1.60],0.4008084642890497
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40581,397,0.94 [0.77-1.16],0.5896543042709597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,35921,340,1.04 [0.72-1.50],0.8309350497037712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,41125,401,1.64 [1.07-2.52],0.0238387435636193
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,34795,332,1.09 [0.82-1.44],0.5479740180986511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,34384,326,0.77 [0.56-1.05],0.0933895075597886
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,35870,341,1.00 [0.67-1.48],0.9862070965824884
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,35263,335,1.03 [0.85-1.26],0.7400808346940311
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,41561,412,1.08 [0.76-1.53],0.6637230222771835
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,34795,332,0.96 [0.75-1.23],0.7354799388853961
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,35854,341,1.10 [1.03-1.18],0.0042494248676076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,34667,329,1.10 [0.73-1.64],0.6544983681574152
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",34974,334,0.97 [0.84-1.11],0.6547991460179939
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,34963,333,0.91 [0.75-1.11],0.3512175521656051
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,35788,340,1.09 [0.93-1.28],0.3016950235177318
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,40581,397,1.03 [0.88-1.19],0.7452461076457864
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,40363,400,1.10 [0.92-1.31],0.2840245689956771
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,34795,332,1.08 [0.87-1.34],0.4927830182043053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,35977,343,0.84 [0.56-1.25],0.3861508488074469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,35854,341,0.97 [0.88-1.07],0.5376878615667389
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,40382,393,1.08 [1.01-1.16],0.0338961436718627
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,34302,322,0.98 [0.78-1.22],0.828600652569647
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,34795,332,0.87 [0.68-1.12],0.2743866328328923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",41125,401,1.04 [0.81-1.35],0.7485823749470608
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,41828,413,1.48 [1.24-1.75],8.518167993031609e-06
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,41323,407,0.95 [0.74-1.21],0.6632664707708511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,40363,400,1.11 [0.88-1.39],0.3947834432543236
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,35921,340,1.09 [0.90-1.31],0.3791235762958936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,40315,392,1.03 [0.85-1.24],0.7949286477286439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,40382,393,1.07 [0.92-1.23],0.3796623328485065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,40382,393,1.03 [0.96-1.10],0.4048084548013471
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,41635,407,1.40 [1.04-1.90],0.0278006166707829
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,41125,401,0.97 [0.64-1.49],0.9029095253988448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,40896,400,1.10 [0.80-1.50],0.565965378838931
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,34788,324,0.88 [0.74-1.06],0.1761649013416267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,40363,400,0.98 [0.85-1.12],0.7595635067324137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,35921,340,0.97 [0.84-1.13],0.7302789335717553
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,35850,339,0.91 [0.73-1.13],0.3833227754987465
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,40627,403,1.09 [0.85-1.41],0.4894173368938996
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,41268,409,1.07 [0.90-1.27],0.4710059103646684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,41018,400,1.09 [0.74-1.60],0.6567529322373459
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,41269,407,1.01 [0.96-1.06],0.6854569847110563
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,40382,393,1.02 [0.97-1.07],0.5156583358062332
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,35152,331,0.93 [0.64-1.36],0.7177057680123767
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,40363,400,1.07 [0.92-1.25],0.3949918283513818
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,41323,407,0.99 [0.89-1.10],0.818235901724579
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,35870,341,1.21 [0.94-1.56],0.1374010012723969
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,35870,341,1.00 [0.87-1.14],0.9529283120749028
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,35152,331,0.88 [0.62-1.25],0.4678372176491061
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,34667,329,1.15 [0.95-1.39],0.1521996364347051
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,34974,334,1.20 [1.00-1.43],0.0494096199507414
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,35854,341,1.19 [0.85-1.65],0.3153662684971194
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,35768,339,0.94 [0.84-1.04],0.2148313394858516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,34891,335,1.24 [1.04-1.48],0.0174643428397429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,34891,335,1.02 [0.91-1.14],0.7223745038118216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,34667,329,0.89 [0.74-1.07],0.2048359342071813
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,39584,387,1.20 [0.87-1.66],0.2604959016581075
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,35082,331,1.15 [0.87-1.53],0.3170762006705954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,41018,400,0.88 [0.71-1.09],0.2385955106033619
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,34891,335,1.25 [0.93-1.68],0.1384817156987595
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,40589,398,1.11 [0.95-1.29],0.1891594797070264
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,41227,402,0.86 [0.66-1.10],0.2295679467346775
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,34824,331,1.00 [0.75-1.33],0.996093455271144
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,41050,404,0.87 [0.75-1.02],0.0931721828012148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",35152,331,0.99 [0.88-1.12],0.8865399953955269
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,40363,400,0.97 [0.79-1.18],0.7310980817750758
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,35757,338,0.92 [0.76-1.12],0.4251067536765083
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,35063,337,1.06 [0.81-1.39],0.6828403846628709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,35921,340,0.95 [0.82-1.10],0.471533348084053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,41794,410,0.85 [0.72-1.01],0.0722318690989139
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,35152,331,0.95 [0.81-1.12],0.5354127271001593
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,35870,341,1.04 [0.93-1.17],0.4811464050400539
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,40382,393,0.95 [0.83-1.10],0.5016038900594573
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,34963,333,0.91 [0.72-1.14],0.3921634551775762
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,41333,409,1.08 [0.92-1.27],0.3600351778226129
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,34974,334,1.06 [0.79-1.42],0.7086231381934451
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,35152,331,0.98 [0.73-1.31],0.8667619643445904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,35870,341,1.02 [0.90-1.17],0.7258514654247559
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,41689,410,1.57 [1.10-2.23],0.0125950893439021
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,41274,403,1.00 [0.92-1.10],0.913841080192802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,35768,339,1.02 [0.82-1.27],0.8593745316642027
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",35930,344,1.06 [0.83-1.36],0.6450272202497453
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,41145,407,0.96 [0.74-1.26],0.7893126961884773
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,34795,332,1.03 [0.89-1.21],0.668246435234418
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,40078,392,1.02 [0.92-1.14],0.6638147314597133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,35152,331,0.98 [0.73-1.32],0.9009923865887304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,41260,409,0.96 [0.87-1.06],0.413196264932571
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,41125,401,1.00 [0.93-1.06],0.8859196563436165
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,41698,408,0.96 [0.72-1.29],0.8002532855003011
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,41018,400,0.95 [0.81-1.11],0.5018020725643426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,35757,338,1.16 [0.95-1.41],0.1405818846460665
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,35768,339,0.87 [0.67-1.12],0.2838897585432265
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,35947,342,1.06 [0.85-1.32],0.5881512568863654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,35768,339,0.99 [0.86-1.13],0.8346116636459404
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,40363,400,0.75 [0.53-1.06],0.103835242325492
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,40213,397,0.88 [0.64-1.20],0.4090451131723847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,34824,331,1.04 [0.87-1.24],0.6941697972230777
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,35870,341,0.92 [0.68-1.25],0.5947615969471045
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,35768,339,0.99 [0.84-1.18],0.9468175309101114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,40589,398,0.97 [0.85-1.11],0.6668933831845523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,35757,338,1.06 [0.89-1.27],0.5170742539060712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,41323,407,1.00 [0.93-1.07],0.9856311575261272
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,35921,340,0.97 [0.82-1.14],0.7146594262667649
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",35870,341,0.92 [0.72-1.18],0.5216281335513435
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",34824,331,1.04 [0.87-1.26],0.64177027368999
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,40589,398,0.94 [0.78-1.14],0.5311103988683463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,41136,408,1.49 [1.04-2.13],0.0297605547029675
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,34974,334,1.04 [0.86-1.27],0.6619822154272565
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",41125,401,1.00 [0.86-1.17],0.9839174006005282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,34473,328,0.99 [0.87-1.13],0.8679878435514188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,40382,393,1.04 [0.94-1.15],0.4706983164561235
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,35809,341,0.75 [0.45-1.27],0.2880476070914091
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",35742,340,0.89 [0.55-1.43],0.6255083130998983
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,41258,406,1.05 [0.95-1.17],0.3218387726149543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,40382,393,1.02 [0.91-1.15],0.7071955595428423
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,34795,332,1.01 [0.88-1.17],0.8777326415882363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,40111,397,1.03 [0.91-1.17],0.6015004283467223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,35854,341,0.97 [0.93-1.02],0.2390046748220828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,35263,335,1.02 [0.88-1.18],0.8052803816626787
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,34963,333,0.98 [0.86-1.12],0.8078418568948624
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,41123,409,1.18 [0.91-1.52],0.2029924399073434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,35263,335,1.00 [0.88-1.14],0.999986590183905
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,34795,332,1.09 [0.84-1.40],0.5247152259322134
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,41513,412,1.04 [0.91-1.20],0.5674118405669619
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",40589,398,1.02 [0.92-1.12],0.7135739493878223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,41794,410,1.17 [0.91-1.51],0.2145293487979542
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,41274,403,0.98 [0.86-1.12],0.783251277841118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,40589,398,1.04 [0.93-1.16],0.5014226601356673
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,34667,329,0.96 [0.77-1.20],0.7452510492804123
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",34795,332,1.04 [0.90-1.20],0.5971627712865092
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",41576,407,0.91 [0.81-1.03],0.1437037888459286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,41698,408,1.01 [0.94-1.08],0.7868410382363665
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",41333,409,0.98 [0.87-1.10],0.729684010648062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,41639,408,1.29 [1.13-1.47],0.0002191522057441
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,41333,409,1.14 [0.89-1.46],0.2952757353097681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,41576,407,0.96 [0.85-1.08],0.504916422504841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,41698,408,0.89 [0.77-1.03],0.1310606883377777
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,35921,340,1.01 [0.92-1.12],0.7652090060385007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,34795,332,0.93 [0.75-1.15],0.5060079696824131
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,41794,410,0.93 [0.80-1.09],0.3967344918501186
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,34891,335,0.98 [0.81-1.18],0.817844591072736
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,34824,331,0.88 [0.73-1.06],0.175320717092979
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,35768,339,0.95 [0.75-1.20],0.664526781646184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,41634,408,0.99 [0.90-1.09],0.8085239637432067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,35854,341,0.99 [0.84-1.16],0.8567421086525955
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,40589,398,1.04 [0.89-1.23],0.5981291599861813
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,35152,331,1.27 [0.86-1.88],0.2257984211764158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,35854,341,0.99 [0.78-1.26],0.9214171920625456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,35921,340,1.19 [0.80-1.75],0.3853184170255003
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,41274,403,0.98 [0.88-1.09],0.7067381671103745
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,41794,410,1.15 [0.89-1.48],0.2788667210333833
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,35612,340,0.80 [0.56-1.14],0.2140791000743766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,40382,393,0.97 [0.87-1.10],0.6653928351052982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,35854,341,1.04 [0.91-1.19],0.5399744805968548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,34891,335,1.23 [1.09-1.40],0.0012593130925149
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,34795,332,0.93 [0.67-1.29],0.6626814900664717
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,35784,341,1.15 [0.93-1.41],0.1940185525900632
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,35870,341,1.01 [0.80-1.29],0.9270259805252292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,40589,398,1.01 [0.73-1.39],0.9705395331110476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",35870,341,0.97 [0.71-1.33],0.8468047567772349
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",41144,401,1.11 [0.87-1.41],0.4005058803226614
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",41274,403,1.19 [0.89-1.61],0.2444880694862675
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,41698,408,0.82 [0.67-1.00],0.0543808937382391
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,35086,331,1.00 [0.83-1.20],0.9761042120294434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",34974,334,1.01 [0.81-1.25],0.9604122977872191
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",34795,332,1.08 [0.86-1.36],0.4997152322413233
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,34600,328,1.24 [1.03-1.48],0.0208930976041938
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,40876,406,0.84 [0.70-1.01],0.0606635140159097
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,40363,400,0.88 [0.71-1.08],0.2277668063086719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,34963,333,0.98 [0.84-1.14],0.7991290204476207
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,40815,399,0.97 [0.80-1.17],0.7371991476796055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,40457,396,1.02 [0.91-1.15],0.7028139707772671
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,35870,341,0.94 [0.76-1.17],0.5793076933591985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,41794,410,0.97 [0.86-1.09],0.6287570430962455
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,40382,393,0.87 [0.68-1.10],0.2435515283821195
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,35456,341,1.01 [0.90-1.13],0.8473079668652943
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,35198,335,0.96 [0.86-1.08],0.5147759903450562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,34974,334,1.12 [0.82-1.51],0.4827251937940238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,35792,343,1.16 [0.84-1.60],0.3777118009558479
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,34974,334,0.97 [0.86-1.09],0.5598853331993469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,41125,401,1.12 [0.88-1.42],0.3462983233989324
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,41698,408,1.18 [0.93-1.49],0.171798675626462
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,34891,335,1.30 [0.98-1.74],0.0729417527993784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,34974,334,0.99 [0.88-1.10],0.7937398103626575
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,41274,403,1.02 [0.82-1.27],0.8682337224163621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,35854,341,0.93 [0.79-1.10],0.4243140972447015
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,34795,332,1.09 [0.89-1.33],0.411580512488776
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,34974,334,0.84 [0.67-1.06],0.1416201941972504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,40176,398,1.00 [0.87-1.14],0.9860193384701936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,41414,403,0.97 [0.86-1.11],0.6910043858775284
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,35757,338,1.10 [0.82-1.49],0.5168350254756494
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,40665,404,0.95 [0.84-1.07],0.3827344902712479
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,41698,408,1.21 [0.97-1.51],0.0859956435887025
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,41017,407,1.14 [0.82-1.58],0.4373544791761112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,34824,331,1.09 [0.96-1.24],0.1739704514195315
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,34824,331,0.91 [0.71-1.17],0.4594981201372634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",41438,410,1.00 [0.87-1.15],0.9989395430134044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,41085,407,1.00 [0.68-1.47],0.984461166135046
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,41828,413,1.18 [0.81-1.71],0.4021896293905747
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,40581,397,1.03 [0.92-1.15],0.5933966813776997
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,41152,408,1.02 [0.75-1.39],0.877387155156479
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,41828,413,1.05 [0.80-1.37],0.7146128657822305
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,41828,413,0.95 [0.68-1.33],0.7620546118409475
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,41274,403,0.81 [0.68-0.95],0.0097883043540204
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,41323,407,1.09 [0.90-1.32],0.3858739859199799
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,41125,401,0.94 [0.59-1.50],0.8082557488734767
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,35263,335,1.10 [0.88-1.37],0.3982235819642891
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,40363,400,1.02 [0.85-1.22],0.8480729033977855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",34974,334,1.01 [0.86-1.20],0.8711383279711554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,41794,410,1.31 [0.48-3.58],0.600755239550919
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,41698,408,0.91 [0.75-1.09],0.2963791025756739
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,34920,334,1.28 [0.99-1.67],0.0634613678132131
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,35263,335,1.09 [0.89-1.32],0.4058184190291751
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,35263,335,1.05 [0.79-1.38],0.7496332541007287
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,35768,339,0.74 [0.48-1.12],0.1557451678307597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,40581,397,0.99 [0.92-1.07],0.8512772498003632
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,41484,405,1.00 [0.66-1.52],0.991888155464314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,41018,400,0.91 [0.77-1.09],0.3147964038530605
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,40363,400,0.93 [0.76-1.13],0.4527629024431036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,34824,331,0.94 [0.78-1.13],0.5114987226744492
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,41274,403,1.17 [0.93-1.49],0.1808165674545833
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,34795,332,0.86 [0.63-1.19],0.376511710024527
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,34963,333,0.88 [0.68-1.13],0.318674036849768
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,35870,341,0.90 [0.76-1.07],0.2417429919725215
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,34824,331,1.05 [0.85-1.29],0.6747689594677028
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,35930,344,0.99 [0.67-1.46],0.9714816896512568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,41125,401,0.96 [0.63-1.44],0.8295057576078242
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,34795,332,1.06 [0.84-1.32],0.6406238628295917
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,41333,409,1.27 [0.87-1.84],0.2138544521816522
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,41764,413,0.93 [0.87-1.00],0.0581433464155095
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,41758,412,1.08 [0.94-1.25],0.2714452417980676
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,41479,412,1.05 [0.80-1.38],0.7330453960223297
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,40809,403,1.22 [1.00-1.48],0.046332593066686
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,41147,410,1.27 [0.97-1.68],0.0837140207769757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,41828,413,1.55 [1.21-1.97],0.0004455136764369
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,41323,407,1.16 [0.89-1.50],0.2728017426332252
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,34891,335,1.05 [0.92-1.20],0.4496131032945537
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,34795,332,1.01 [0.84-1.22],0.8896452460745111
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,35916,343,0.94 [0.61-1.45],0.7788265541663201
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,34667,329,0.97 [0.86-1.09],0.6093191225263128
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,34974,334,0.80 [0.60-1.07],0.1277215695383463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,41125,401,1.34 [1.04-1.72],0.0226347481901048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,41323,407,1.07 [0.80-1.42],0.6689057941068657
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,35921,340,1.04 [0.92-1.18],0.52246553706141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,41274,403,1.01 [0.92-1.11],0.8312773258156262
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,40382,393,1.07 [0.97-1.17],0.1717807236514189
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,40581,397,1.03 [0.93-1.15],0.5616468687552933
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,40581,397,1.00 [0.86-1.17],0.9848511534885154
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,41484,405,1.13 [0.83-1.52],0.435162913200687
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,40581,397,0.99 [0.86-1.14],0.8810072536280554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,41125,401,1.06 [0.95-1.19],0.299383872929259
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,41794,410,1.11 [0.95-1.31],0.1861564979127541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,40581,397,1.09 [0.86-1.38],0.4805979415220321
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,34891,335,0.86 [0.65-1.12],0.2590726296360005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,40581,397,1.12 [0.97-1.30],0.1279207126132514
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,40792,402,1.03 [0.70-1.52],0.8646340914196307
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,34824,331,0.92 [0.64-1.32],0.6563494752827936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,41274,403,1.02 [0.78-1.33],0.8834614759105988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,40581,397,1.01 [0.79-1.31],0.9169422988715136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,41794,410,0.78 [0.63-0.97],0.0279528825786817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,40517,397,0.96 [0.78-1.19],0.7385785916218146
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,40581,397,1.00 [0.88-1.13],0.9951071977641144
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,40581,397,1.04 [0.81-1.34],0.7777352508846787
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,40581,397,1.01 [0.90-1.14],0.8201973772540494
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,41333,409,1.13 [0.93-1.38],0.2251474187690476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,40751,396,1.09 [0.92-1.29],0.3134511625014126
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,41143,401,0.90 [0.73-1.09],0.2793922154505133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,41479,412,1.11 [0.84-1.47],0.4636048263504986
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,41794,410,1.42 [1.09-1.85],0.0088104259518467
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,40754,395,0.98 [0.93-1.03],0.4185787475759538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,40287,396,1.04 [0.92-1.18],0.53238805239165
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,40581,397,1.08 [0.94-1.23],0.2873205717889626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,40394,396,1.04 [0.89-1.21],0.662724691666591
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,41268,409,1.20 [0.82-1.75],0.3507879734089631
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,41225,403,1.26 [0.80-1.97],0.3151518924465613
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,41333,409,1.13 [0.94-1.37],0.1934400389799637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,41700,413,1.02 [0.85-1.24],0.7997862202451884
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,40581,397,0.94 [0.74-1.19],0.6114576383802629
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,41218,403,1.02 [0.86-1.20],0.819536311607493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,40581,397,0.90 [0.68-1.19],0.450843003458621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,40581,397,0.95 [0.78-1.14],0.5594583937768121
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,40581,397,0.98 [0.80-1.21],0.8734601334563457
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,34891,335,0.98 [0.76-1.27],0.8802464400677826
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,34891,335,1.08 [0.91-1.29],0.3624280117479697
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,35757,338,1.04 [0.90-1.21],0.607565448621803
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,40581,397,1.13 [0.95-1.35],0.1622285114365293
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,40581,397,1.01 [0.84-1.20],0.9497745974094034
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,34539,329,1.05 [0.77-1.43],0.7719324965146209
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,41037,407,1.19 [0.96-1.48],0.1097314283267361
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,40581,397,1.09 [0.87-1.37],0.4323911395169546
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,35757,338,1.08 [0.82-1.42],0.5712742332377185
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,34667,329,1.09 [0.91-1.30],0.3536960202400004
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,34891,335,1.08 [0.90-1.28],0.4201362569614448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,34759,334,1.00 [0.76-1.32],0.9993972457691884
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,41274,403,1.02 [0.83-1.25],0.8734603806881849
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,40581,397,0.94 [0.75-1.18],0.595716803399653
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,40301,398,0.90 [0.70-1.15],0.3914128527669837
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,34891,335,0.99 [0.82-1.19],0.8997424201479289
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,34763,334,0.90 [0.76-1.06],0.209363678752893
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,40581,397,1.13 [0.86-1.49],0.3919984814281003
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,40581,397,0.96 [0.88-1.06],0.4417923880490969
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,41274,403,1.04 [0.81-1.33],0.7670987786298336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,40581,397,1.00 [0.94-1.07],0.9959090800932864
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,41274,403,0.89 [0.76-1.05],0.1683001132946988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,41125,401,0.98 [0.87-1.10],0.7548563663684307
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,41082,407,0.85 [0.66-1.09],0.1996653610847998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,41323,407,1.02 [0.61-1.69],0.9415902288130398
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,41274,403,0.97 [0.84-1.11],0.662412640088421
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,41333,409,0.95 [0.80-1.12],0.5302350038202344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,35263,335,0.95 [0.78-1.16],0.6347845669076377
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,40307,400,0.96 [0.83-1.13],0.6485058374002035
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,35757,338,0.93 [0.72-1.18],0.5332911459984251
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,41018,400,0.97 [0.84-1.13],0.7162464016653105
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,35854,341,0.97 [0.81-1.17],0.765171400974481
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,34824,331,0.80 [0.55-1.17],0.2454044175712887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,40286,399,0.95 [0.78-1.15],0.5966471881792557
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,35152,331,1.08 [0.88-1.32],0.4708050755786505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,41333,409,1.09 [0.87-1.36],0.4488858904508991
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,41125,401,0.99 [0.84-1.18],0.9529854696661116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",34974,334,0.92 [0.76-1.11],0.3619305162103162
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",35870,341,0.93 [0.72-1.21],0.5956953502857338
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",41125,401,1.02 [0.93-1.12],0.6795458676618732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,35854,341,1.00 [0.88-1.13],0.9903181318709968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,35757,338,0.92 [0.74-1.16],0.485323610274975
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,35768,339,1.04 [0.94-1.16],0.4274921898439981
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,34891,335,1.23 [0.66-2.31],0.5079329392349237
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,40949,400,0.99 [0.90-1.09],0.8132750440435907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,41125,401,1.02 [0.86-1.20],0.8269819928078272
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40589,398,0.97 [0.88-1.08],0.5878308742679423
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,40581,397,1.02 [0.89-1.16],0.7922309455745338
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,41274,403,0.99 [0.91-1.08],0.8922556551246084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39773,392,0.90 [0.71-1.14],0.3837906212307098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,41274,403,0.89 [0.71-1.12],0.3280038804663188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,35930,344,1.06 [0.84-1.34],0.6213086035451543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,35502,339,0.95 [0.86-1.06],0.3872791723287695
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,41274,403,0.71 [0.55-0.92],0.0107591019174957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,35152,331,0.90 [0.66-1.22],0.5045379289324949
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,41333,409,1.30 [0.91-1.85],0.1430585099889555
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,41274,403,0.96 [0.81-1.14],0.6506488927103979
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,34891,335,1.16 [0.90-1.49],0.2427779187640285
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,41333,409,0.88 [0.67-1.17],0.3873183477897681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,41698,408,0.64 [0.38-1.07],0.0899105515692078
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,35263,335,1.10 [0.91-1.32],0.3337192600554685
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,41286,412,0.79 [0.52-1.20],0.2706265192596816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,40382,393,1.06 [0.85-1.33],0.5897852281627092
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,40589,398,1.00 [0.92-1.08],0.9965735337877312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,41086,407,0.97 [0.70-1.33],0.8310026096334546
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,41438,410,0.81 [0.64-1.03],0.0870801621859433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,40581,397,1.02 [0.76-1.37],0.8805800199654724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,41698,408,1.06 [0.88-1.28],0.554971750765091
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,35930,344,1.36 [1.05-1.78],0.0215935002174357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,35977,343,1.09 [0.63-1.89],0.7523603982233911
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,41479,412,1.14 [0.90-1.43],0.2821928473490054
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,35977,343,0.96 [0.63-1.46],0.8453555538394483
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,35757,338,0.94 [0.74-1.19],0.6107495282272433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,41274,403,0.99 [0.85-1.14],0.847473995486019
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,34795,332,1.03 [0.88-1.21],0.7071500815190735
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",34974,334,0.97 [0.83-1.14],0.7070727487613259
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",34824,331,0.87 [0.67-1.13],0.2929721784057176
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",40363,400,1.07 [0.90-1.26],0.4615106064621841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,34667,329,1.08 [0.87-1.33],0.4795424807372146
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,41689,410,1.38 [1.00-1.89],0.0482958982344179
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,35152,331,1.05 [0.85-1.29],0.6778854217549751
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,40581,397,1.06 [0.92-1.23],0.4263656933623079
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,34667,329,0.91 [0.75-1.11],0.34001745645155
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,35768,339,0.96 [0.85-1.09],0.5411797355286238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,40581,397,1.00 [0.83-1.20],0.9927221773847876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,41125,401,1.05 [0.86-1.27],0.6560861989651516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,35768,339,0.98 [0.88-1.08],0.6401725318921232
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,34824,331,1.10 [0.92-1.31],0.3193568651761179
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,34963,333,0.99 [0.86-1.13],0.8460254124878336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,40363,400,1.06 [0.90-1.25],0.5022816330555261
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,35173,336,1.18 [0.95-1.47],0.1325498870026115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,34891,335,1.03 [0.91-1.15],0.6650686242997501
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,41438,410,1.05 [0.74-1.48],0.7885928362442974
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,40363,400,0.88 [0.69-1.12],0.2919619961495817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,34667,329,0.98 [0.83-1.14],0.7666345802972074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,34974,334,0.93 [0.78-1.10],0.3742277465891883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,35854,341,1.03 [0.74-1.43],0.8721112476797972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,35263,335,1.00 [0.86-1.16],0.9598362941189468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,35263,335,0.77 [0.53-1.14],0.1965247520407469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,35757,338,1.10 [0.93-1.31],0.2734944163797885
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,34795,332,0.99 [0.73-1.35],0.9692460011138404
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,34824,331,1.00 [0.87-1.15],0.9949348658224432
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,34795,332,1.01 [0.92-1.09],0.9084137103859864
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,41125,401,0.97 [0.88-1.08],0.6184070251789766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,35757,338,1.17 [1.04-1.31],0.0077621202432774
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,40382,393,1.11 [0.99-1.24],0.0662624009375238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,35768,339,1.04 [0.98-1.10],0.2127602468945382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,40382,393,0.97 [0.91-1.05],0.4640275159114901
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,34667,329,0.88 [0.75-1.02],0.0844309474324459
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,34824,331,0.92 [0.76-1.13],0.4444058278005064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,40363,400,1.12 [0.90-1.39],0.3051289654874634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,41419,411,0.98 [0.73-1.31],0.8834873417979507
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,41323,407,0.86 [0.68-1.09],0.2021128639037372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,40363,400,1.02 [0.91-1.15],0.6909876158369401
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,34824,331,0.86 [0.66-1.13],0.2873718147187772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,35870,341,1.19 [0.98-1.44],0.08015841806229
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,40911,407,1.00 [0.94-1.07],0.9602519273290676
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,41312,409,0.89 [0.71-1.10],0.2779759327183299
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,41028,407,1.00 [0.76-1.32],0.9924987093518118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,40382,393,1.03 [0.96-1.10],0.4140681921129566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,40389,399,1.06 [0.87-1.29],0.5444579178617892
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,41698,408,0.87 [0.72-1.05],0.1539722403214541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,35699,336,1.10 [0.90-1.35],0.3517734035545982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,35930,344,1.18 [1.07-1.30],0.0012772511421198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,41698,408,1.12 [0.98-1.28],0.1022610724677433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,41373,409,0.84 [0.63-1.11],0.2113187951044564
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,34246,325,1.16 [0.88-1.53],0.2825570585543474
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,39930,394,1.11 [0.87-1.41],0.4181055596243178
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,35262,341,0.86 [0.57-1.31],0.4897077475052117
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,41794,410,1.26 [1.00-1.57],0.046793124113579
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,34824,331,1.01 [0.84-1.20],0.9260793449634382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,41794,410,1.30 [1.08-1.57],0.0048752601224536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,34891,335,1.20 [0.97-1.48],0.0910132312298617
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,35854,341,1.09 [0.87-1.35],0.4573914126105819
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",39079,389,1.07 [0.79-1.44],0.664689945467094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",34795,332,1.24 [0.97-1.58],0.0891435680377389
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",41125,401,1.09 [0.98-1.21],0.1225803240331845
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",41210,403,1.17 [1.03-1.32],0.0163221910511028
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",40363,400,0.99 [0.83-1.18],0.927674745934197
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",34795,332,0.87 [0.64-1.18],0.3822508534797773
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",34824,331,1.10 [0.97-1.24],0.1262758496712429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,41253,407,0.92 [0.79-1.08],0.3184657875645958
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,41794,410,1.00 [0.82-1.21],0.9715146045570384
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,41438,410,1.04 [0.77-1.41],0.781030307962858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,35921,340,0.97 [0.87-1.09],0.6507885664892727
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,35686,338,0.96 [0.76-1.20],0.701243025258091
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,41323,407,0.99 [0.86-1.13],0.8710620491413247
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,41125,401,1.02 [0.82-1.28],0.8590464293437177
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,41283,403,1.06 [0.83-1.34],0.6579676418714698
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,41018,400,1.04 [0.95-1.13],0.3854992260782317
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,34795,332,0.91 [0.73-1.14],0.4055997403153623
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,41484,405,0.96 [0.74-1.24],0.739757561540879
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,34974,334,0.95 [0.67-1.34],0.755239293275798
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,34941,334,1.07 [0.73-1.56],0.7459066386238329
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,40070,394,1.66 [1.06-2.60],0.02782651093313
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,41720,409,1.05 [0.89-1.24],0.5411877022509661
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,35757,338,0.88 [0.67-1.15],0.3571997985600388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,40581,397,0.96 [0.80-1.16],0.677286765489993
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,35757,338,0.97 [0.82-1.15],0.7407021435038338
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,41794,410,0.99 [0.88-1.11],0.8553137869141896
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,41125,401,1.05 [0.98-1.12],0.200189102979416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,34891,335,1.05 [0.92-1.18],0.478466944943541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,40941,399,1.21 [0.95-1.56],0.1281355150112888
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,41479,412,1.05 [0.90-1.22],0.5234730868420381
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,41689,410,0.91 [0.79-1.04],0.1582677499923023
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,35947,342,0.92 [0.58-1.47],0.7310093036998851
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,35870,341,1.04 [0.88-1.22],0.6636979809035339
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,40089,400,0.90 [0.71-1.13],0.3589397485745477
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,35930,344,0.95 [0.77-1.18],0.6591046128478459
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,41435,411,0.91 [0.76-1.07],0.2573753811964515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,35870,341,1.03 [0.93-1.15],0.5655316509556794
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,35921,340,0.98 [0.84-1.15],0.8110831140606602
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,41635,407,0.91 [0.76-1.07],0.2566918518032839
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,33939,316,1.13 [0.96-1.32],0.1303551719411777
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,34824,331,0.90 [0.77-1.06],0.1993866535142081
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,35870,341,1.25 [0.98-1.60],0.072465447882261
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEP,Leptin,41323,407,0.94 [0.83-1.07],0.3675225746097523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,41323,407,0.82 [0.62-1.09],0.1755574138758903
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,35870,341,1.01 [0.83-1.22],0.938697198420274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,41323,407,1.12 [0.87-1.44],0.3690688735302397
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,41435,411,0.98 [0.73-1.31],0.8716713644975251
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,35977,343,1.17 [0.85-1.61],0.337362473244722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,41283,403,1.30 [1.12-1.51],0.00052140295563
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,41253,403,1.06 [0.86-1.30],0.5919265803894248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,41689,410,1.02 [0.88-1.18],0.8152097334201444
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,41297,404,1.11 [0.83-1.48],0.4734054820497496
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,41484,405,1.25 [0.98-1.58],0.0731695684847415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,40382,393,0.99 [0.90-1.10],0.9019056358945868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,41344,403,0.90 [0.78-1.04],0.1624595148528114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,40363,400,1.09 [0.93-1.28],0.306008309716108
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,41274,403,0.97 [0.67-1.41],0.8780896790169728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,41333,409,0.96 [0.75-1.22],0.7401170999193043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,35930,344,1.06 [0.98-1.15],0.1598340931043386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,34795,332,0.97 [0.78-1.20],0.7672754612087358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,41269,407,1.17 [0.89-1.54],0.248299346342414
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,35921,340,0.95 [0.82-1.09],0.4293401645278262
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,41828,413,1.15 [0.84-1.59],0.3831961892355889
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,41630,412,0.99 [0.77-1.27],0.9252470225295524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40581,397,1.12 [0.92-1.37],0.2675030650735613
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,41828,413,0.98 [0.87-1.11],0.7436098948416336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,34974,334,1.01 [0.85-1.19],0.9528206988954476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,35698,339,0.96 [0.81-1.14],0.6384303074655684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,35854,341,1.24 [0.86-1.78],0.2447684432251607
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,35870,341,1.08 [0.80-1.45],0.6157826635412076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,34824,331,0.92 [0.76-1.10],0.356749426228182
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",34974,334,0.93 [0.82-1.05],0.2260851622168747
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),35128,338,1.02 [0.96-1.08],0.5448456764804486
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,41125,401,0.96 [0.77-1.19],0.7173005512187314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,41323,407,0.85 [0.71-1.02],0.0761716323216491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,39965,388,1.19 [1.02-1.38],0.0229069916103831
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,34795,332,1.08 [0.92-1.27],0.3737091129701702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,34795,332,1.02 [0.87-1.19],0.828311719619764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,34963,333,1.06 [0.85-1.33],0.6048058094235083
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,35977,343,1.57 [1.07-2.31],0.0212812014710021
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,41576,407,1.07 [0.83-1.37],0.5970928444927137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,34767,334,1.04 [0.71-1.51],0.8583047170298118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,41125,401,1.03 [0.74-1.43],0.8628150931727943
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,41323,407,1.08 [0.85-1.37],0.5283496466743602
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,34963,333,0.97 [0.72-1.30],0.8330583223649601
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,34963,333,0.92 [0.80-1.06],0.2381688951067088
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,41689,410,1.10 [0.96-1.27],0.1831596098188105
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,41125,401,1.07 [0.85-1.34],0.5494273809979489
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,35768,339,1.16 [0.91-1.47],0.2218900715541982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,34963,333,1.10 [0.89-1.35],0.3898508651951374
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,35921,340,1.00 [0.81-1.25],0.980985087366462
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,35757,338,0.93 [0.74-1.15],0.4962827238898961
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,40581,397,0.82 [0.65-1.02],0.0749115649259924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,34963,333,0.85 [0.65-1.12],0.2516033818540634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,35870,341,0.79 [0.52-1.19],0.2600671858072012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,40382,393,0.96 [0.81-1.13],0.6054754321793043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,35263,335,1.06 [0.94-1.20],0.3099071808314014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,41274,403,0.86 [0.69-1.08],0.1905007757424021
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,41274,403,0.87 [0.70-1.09],0.232672069229377
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,41698,408,0.98 [0.84-1.13],0.7733858422016653
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,35757,338,1.07 [0.81-1.41],0.6412559892173839
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,41828,413,1.24 [0.94-1.64],0.1278127329682194
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,40382,393,1.09 [0.92-1.28],0.3214788103284148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,41087,401,1.20 [0.89-1.62],0.2362386628183744
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,40581,397,1.03 [0.83-1.28],0.8010268648540244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,35757,338,1.00 [0.79-1.27],0.9988619963259922
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LXN,Latexin,40830,398,0.91 [0.80-1.04],0.1610881124656104
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,41095,402,1.06 [0.84-1.33],0.6257822743135049
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,41274,403,1.06 [0.84-1.33],0.6310131466851716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,40872,402,1.28 [0.94-1.74],0.1121512594270999
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,41018,400,0.87 [0.68-1.12],0.278463949212997
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,40382,393,0.85 [0.70-1.03],0.0977116214342347
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,41125,401,1.03 [0.93-1.14],0.6145046218601784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,40363,400,0.97 [0.84-1.12],0.6444218308720331
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,41109,408,0.84 [0.65-1.10],0.20710335889059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,40382,393,0.82 [0.68-0.99],0.0429900288922272
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,34824,331,0.93 [0.83-1.03],0.1763003727762697
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,34963,333,1.03 [0.93-1.13],0.6052197946991044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,35977,343,1.13 [0.67-1.92],0.6409133069281199
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,34667,329,0.85 [0.63-1.15],0.2958235917816028
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,35152,331,1.05 [0.90-1.22],0.5231028236429198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,34974,334,1.02 [0.78-1.34],0.8626270340868714
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40876,399,0.98 [0.82-1.18],0.8625677913456211
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,40382,393,0.87 [0.68-1.11],0.2490226342141803
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,34963,333,0.94 [0.76-1.17],0.5856211300745431
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,35263,335,0.93 [0.83-1.05],0.2370377500137241
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,40382,393,0.96 [0.79-1.16],0.6440475153607732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,35921,340,1.08 [0.80-1.44],0.6175197896741349
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,35757,338,1.05 [0.88-1.27],0.5856260313762883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",34974,334,1.33 [0.88-2.03],0.1768018559992787
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,35921,340,0.98 [0.82-1.16],0.7934268830129684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",34667,329,0.87 [0.70-1.07],0.1912683497631073
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,41484,405,0.98 [0.91-1.06],0.6272320043829043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,41438,410,0.91 [0.66-1.25],0.5537707684639814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,34795,332,0.99 [0.85-1.15],0.8457033564400044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,34824,331,0.94 [0.67-1.32],0.721204347246053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,34795,332,1.13 [0.99-1.29],0.0616910246526654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,35854,341,1.08 [0.87-1.35],0.4953984576355436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,35768,339,1.00 [0.85-1.18],0.9811908571593376
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,41274,403,0.99 [0.90-1.08],0.7726573549049995
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,40382,393,0.99 [0.90-1.09],0.8709130023155002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40941,399,1.00 [0.92-1.08],0.9889058940357428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,34667,329,1.00 [0.78-1.28],0.984632825234916
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,41274,403,0.96 [0.78-1.18],0.6763716474467591
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,35263,335,0.95 [0.82-1.10],0.4928105071540053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,34667,329,1.00 [0.93-1.08],0.9357169113289252
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,40363,400,1.06 [0.89-1.26],0.5302032462586896
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,41323,407,1.13 [0.80-1.59],0.4741910578870499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",35082,331,1.00 [0.89-1.14],0.952672368188104
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,40941,399,1.31 [0.89-1.92],0.1717008857132883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,41356,404,1.32 [0.98-1.78],0.0719066359331093
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,40949,400,1.07 [0.82-1.40],0.6197492152968223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,40382,393,1.01 [0.91-1.11],0.879089962890415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAX,Protein max,40363,400,1.02 [0.94-1.11],0.6832851197826897
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,41828,413,1.26 [1.08-1.46],0.0025789472054661
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,35474,341,1.01 [0.92-1.11],0.8393435936755267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,41479,412,0.82 [0.62-1.07],0.1367193134082922
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",35870,341,1.23 [0.99-1.53],0.0664014870482919
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,34891,335,0.96 [0.85-1.08],0.4865059580311706
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,41124,402,1.10 [0.90-1.34],0.3696485490224879
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,35768,339,0.72 [0.46-1.11],0.1323613644055643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,41018,400,0.98 [0.86-1.11],0.7267853353904069
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",35744,342,0.99 [0.76-1.28],0.917239476869271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDK,Midkine,41315,409,1.04 [0.88-1.23],0.6375455634551759
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,34963,333,1.17 [0.83-1.64],0.3760823117955403
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",34974,334,0.94 [0.84-1.06],0.3053716204523906
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,40382,393,0.98 [0.87-1.10],0.6868775558172326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,34795,332,0.86 [0.67-1.09],0.2160691487755852
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,41283,403,0.84 [0.67-1.06],0.1420524843284901
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,34795,332,1.04 [0.76-1.42],0.821656475706998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,41700,413,0.89 [0.57-1.40],0.6134461458433735
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,35921,340,0.86 [0.60-1.22],0.3913157594332044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,35152,331,0.54 [0.34-0.84],0.0065268692136643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,35768,339,1.09 [0.95-1.26],0.2147116312124917
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,41323,407,0.92 [0.86-0.99],0.0290483134035427
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,41283,403,0.86 [0.60-1.22],0.4015404846018779
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,41794,410,1.18 [0.83-1.66],0.3625455107829207
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,41333,409,0.99 [0.92-1.06],0.708975621089494
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,41427,408,1.13 [0.73-1.77],0.5785137791554451
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,40363,400,0.96 [0.70-1.30],0.7759786046136862
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",41274,403,0.95 [0.85-1.06],0.3441502162519753
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,41635,407,0.88 [0.76-1.02],0.1001660219410067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,40589,398,0.92 [0.76-1.12],0.4138859373272848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,34963,333,1.05 [0.90-1.22],0.5177515701391522
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,35152,331,1.24 [0.89-1.72],0.2020035419319563
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,41828,413,1.07 [0.86-1.32],0.5562260973578652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,41333,409,1.21 [0.99-1.47],0.0567779420277112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,41423,404,1.00 [0.91-1.11],0.9555482836099528
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,41274,403,0.98 [0.91-1.06],0.631317703608325
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,41438,410,1.13 [0.89-1.42],0.3101011876797186
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,34963,333,0.97 [0.83-1.14],0.7519538505558587
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,41274,403,0.99 [0.94-1.05],0.7965731534509077
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,41266,407,0.90 [0.79-1.02],0.100091357382051
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,40581,397,1.02 [0.86-1.22],0.7864521416673894
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,35757,338,0.96 [0.88-1.06],0.4665480043017865
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,35854,341,0.98 [0.88-1.09],0.7008119963350581
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,41018,400,0.99 [0.91-1.09],0.857402924720651
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,34891,335,1.13 [0.89-1.45],0.3138535695430974
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,34667,329,1.11 [0.96-1.28],0.1499050896480429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,41274,403,1.08 [0.98-1.19],0.1409423653616438
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,41125,401,1.03 [0.92-1.15],0.5923471147433077
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,39836,396,1.03 [0.93-1.13],0.6098949703907145
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,41230,404,1.03 [0.89-1.20],0.6764930143267338
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,41386,406,1.20 [1.03-1.40],0.0223636274967076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,40363,400,1.20 [0.91-1.57],0.1991402229199357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,35921,340,1.11 [0.92-1.34],0.289335796056924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,41333,409,1.05 [0.88-1.25],0.5925401753573537
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,40524,398,1.40 [1.16-1.69],0.000486398621867
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,41618,409,0.94 [0.83-1.06],0.3143038283925192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,41272,409,0.96 [0.83-1.11],0.5956253440223608
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",34795,332,1.02 [0.82-1.26],0.8779505137309856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,34963,333,0.96 [0.80-1.16],0.6810922311533063
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,35263,335,0.86 [0.66-1.11],0.2408315245796038
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,41258,406,0.90 [0.82-0.99],0.0248309533039203
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,35152,331,1.05 [0.89-1.23],0.5508326370857488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,41698,408,0.93 [0.71-1.20],0.5723006315241663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,35854,341,1.10 [0.77-1.58],0.6092412336245819
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,35263,335,1.26 [1.02-1.57],0.0355898489668622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,34667,329,1.06 [0.81-1.40],0.6557994434216263
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,34667,329,1.06 [0.93-1.20],0.382816294687205
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,40589,398,0.95 [0.84-1.07],0.3724969818939917
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,41125,401,0.98 [0.89-1.09],0.7447056378870485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,41423,404,0.97 [0.87-1.09],0.6513225484568217
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,41333,409,0.91 [0.75-1.10],0.3325264018637991
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,35686,337,0.98 [0.77-1.24],0.8442779257225799
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,35947,342,1.38 [0.96-1.97],0.0799353647401058
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,34963,333,0.90 [0.77-1.05],0.1927227353505972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",34795,332,1.18 [0.92-1.51],0.1952801206126224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",35870,341,0.97 [0.73-1.29],0.8280155657803957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",40363,400,0.89 [0.64-1.24],0.481226153264469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",34600,328,1.13 [0.80-1.61],0.4770671314181549
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",35870,341,0.98 [0.84-1.13],0.7636271938691733
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",34891,335,1.15 [0.82-1.61],0.423392561410246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,41064,401,1.05 [0.91-1.22],0.4881880512740301
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,34963,333,1.17 [0.90-1.51],0.2460008986418153
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,41218,408,1.11 [0.98-1.26],0.0972583040436061
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,41689,410,1.06 [0.88-1.29],0.5204398087364228
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,41438,410,0.97 [0.86-1.09],0.5661999190784078
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,35406,340,0.95 [0.83-1.09],0.4742878529036959
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,40589,398,0.97 [0.82-1.15],0.763829093198207
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,34891,335,1.00 [0.89-1.12],0.970073522512529
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",35854,341,1.27 [0.87-1.86],0.2130964632320117
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,35263,335,1.01 [0.92-1.11],0.776152878288822
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",35768,339,0.95 [0.84-1.07],0.3891419921720307
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,40589,398,1.11 [0.86-1.42],0.4380391456307245
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,34795,332,1.10 [0.95-1.27],0.2198895121490468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,35768,339,1.00 [0.91-1.10],0.9418781145571384
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,35757,338,1.01 [0.91-1.12],0.9017425630872408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,35263,335,0.98 [0.81-1.19],0.834953317178772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,40363,400,1.11 [0.93-1.31],0.2526528125976195
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,41125,401,1.02 [0.97-1.07],0.3767911948889764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,35930,344,0.95 [0.85-1.06],0.3391507388916455
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,34667,329,1.03 [0.81-1.31],0.7877118735459537
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,40581,397,1.03 [0.92-1.15],0.6599042802166983
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,35152,331,0.75 [0.53-1.06],0.1068349333660468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",35921,340,1.21 [1.06-1.38],0.004805201592242
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",34974,334,1.05 [0.94-1.19],0.3871246100396612
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,35870,341,0.89 [0.75-1.05],0.1730187381225734
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,35921,340,1.01 [0.91-1.12],0.8930836101432502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,34795,332,1.03 [0.81-1.30],0.811856852284461
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,34667,329,1.00 [0.79-1.28],0.9865867639134468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,35930,344,0.94 [0.86-1.03],0.1703014271627458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",34795,332,1.09 [0.84-1.42],0.5201731014299468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,34974,334,1.15 [1.00-1.33],0.0441826701804703
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,34974,334,0.84 [0.68-1.04],0.107581669346297
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,34963,333,0.97 [0.86-1.09],0.5849770289060423
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",34963,333,1.10 [0.90-1.33],0.3572746163128713
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,35870,341,0.92 [0.69-1.23],0.5558910720458837
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,40581,397,0.97 [0.84-1.11],0.6417751520679371
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,41333,409,0.88 [0.72-1.07],0.1996359862736036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,34824,331,1.27 [1.07-1.51],0.0074826339323691
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,34795,332,1.12 [0.92-1.37],0.2402460466357739
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,35152,331,1.13 [1.01-1.26],0.0313652891035023
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,41417,405,1.08 [0.91-1.28],0.3784935661556838
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,40382,393,1.00 [0.84-1.19],0.9829308612641018
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,34795,332,1.07 [0.87-1.32],0.4983865727284078
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,34963,333,1.01 [0.92-1.10],0.8675576585740902
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,40833,400,0.89 [0.76-1.03],0.1221563314978333
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,35757,338,1.10 [0.92-1.32],0.2890756599224054
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,41323,407,0.89 [0.76-1.05],0.1802257724072827
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,34824,334,1.06 [0.89-1.27],0.5052531174997753
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,34908,333,0.95 [0.78-1.15],0.5833786735922095
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,35152,331,0.98 [0.60-1.60],0.9363703912954076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,40382,393,0.88 [0.74-1.06],0.1827840694075292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,35701,338,0.88 [0.69-1.12],0.2973231237329646
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,35854,341,0.95 [0.69-1.30],0.7364158378289347
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",35870,341,0.95 [0.77-1.19],0.676830161327094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,41438,410,1.18 [0.86-1.63],0.3091413106332168
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,40581,397,0.83 [0.68-1.01],0.0599043769419314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,41479,412,1.06 [0.80-1.40],0.6743114987999965
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,41333,409,0.87 [0.63-1.21],0.4078193462191044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,41689,410,1.06 [0.84-1.33],0.6399974176301011
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,41207,403,0.87 [0.77-0.97],0.011248713341866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,41484,405,1.01 [0.93-1.10],0.7342651189172595
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,40581,397,1.02 [0.86-1.21],0.8286289449704818
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,41215,402,1.04 [0.82-1.32],0.7255999189710443
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,35768,339,1.25 [0.93-1.69],0.1395934303634121
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,41698,408,1.42 [1.05-1.92],0.0244132724476031
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,40363,400,1.06 [0.93-1.20],0.3767691583117606
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,35757,338,0.93 [0.78-1.12],0.45014259369275
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,34828,335,1.35 [1.01-1.79],0.0430979373815489
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,35768,339,0.94 [0.84-1.06],0.3461610312604521
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",40382,393,1.02 [0.91-1.14],0.7138192724800062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,34795,332,1.16 [0.90-1.50],0.2599631597940275
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,34795,332,1.01 [0.86-1.19],0.8840656986445192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,34891,335,1.02 [0.75-1.41],0.881084731240098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,41269,407,1.30 [0.98-1.73],0.0679136212450643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,41438,410,1.19 [0.91-1.56],0.1984315149358033
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,34891,335,0.97 [0.78-1.20],0.759640059361608
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,34891,335,0.94 [0.68-1.29],0.68396587542753
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,40230,398,1.13 [0.93-1.38],0.2034986886844644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,35263,335,1.06 [0.93-1.21],0.3893623320924648
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,41438,410,0.90 [0.73-1.10],0.3040756139075798
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,41484,405,1.31 [0.97-1.76],0.0748275271139034
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,35757,338,0.98 [0.89-1.07],0.6114417249237609
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,35870,341,0.97 [0.61-1.54],0.90712219854931
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,35947,342,1.00 [0.86-1.16],0.9518283063513134
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,41794,410,1.69 [1.25-2.27],0.0005978351683791
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,34891,335,0.95 [0.84-1.09],0.4790404020536883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",41274,403,1.01 [0.93-1.11],0.7651034168238572
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40581,397,1.06 [0.92-1.23],0.4359938676013078
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,34974,334,0.95 [0.82-1.10],0.4769915711510396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,35870,341,0.89 [0.68-1.16],0.3778061212493108
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,34795,332,1.00 [0.87-1.16],0.9660067167270268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,35263,335,0.99 [0.82-1.20],0.900922090262696
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,40382,393,0.95 [0.79-1.15],0.6317132678941122
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",35768,339,0.97 [0.87-1.07],0.5140099816652698
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,34795,332,0.99 [0.85-1.16],0.924041965683386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,34795,332,0.83 [0.62-1.12],0.2289888687744878
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,41018,400,1.27 [0.63-2.56],0.5041955894967671
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,35921,340,1.25 [0.91-1.71],0.164691058834547
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,35854,341,1.28 [0.83-1.96],0.2572560789279404
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,34306,329,1.20 [0.85-1.70],0.2899352923305647
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,41347,411,1.02 [0.81-1.29],0.8459880778034852
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,41333,409,0.98 [0.87-1.10],0.7622824693184053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,40382,393,0.96 [0.80-1.14],0.6292097851584214
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,34974,334,0.91 [0.72-1.14],0.3946852097732286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,35791,339,0.95 [0.82-1.09],0.4629583581905681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,34963,333,0.98 [0.83-1.15],0.7916174376088253
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,34824,331,1.16 [0.95-1.41],0.1351811474550227
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,34891,335,1.52 [0.95-2.41],0.0790968174013295
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,41356,404,0.86 [0.58-1.27],0.4560119988604274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,35620,338,1.01 [0.87-1.17],0.8820002187946716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,41018,400,0.87 [0.76-0.99],0.0337919675886022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,34667,329,0.91 [0.69-1.22],0.5351897426535438
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,35870,341,0.97 [0.83-1.14],0.7101484499114215
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,41333,409,1.17 [0.80-1.71],0.409550703374048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,34795,332,1.06 [0.97-1.15],0.2330722378663057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",40363,400,1.09 [0.93-1.28],0.2854279102209562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",34795,332,1.04 [0.80-1.35],0.7877101599702758
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",40363,400,1.14 [0.97-1.34],0.099324639584267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,41828,413,1.15 [0.66-1.99],0.6308758473296543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,35930,344,1.05 [0.64-1.72],0.8601152347826901
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,41828,413,0.82 [0.63-1.06],0.1339421846165317
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,35331,341,1.29 [0.95-1.77],0.1055819752304997
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,41323,407,1.10 [0.84-1.44],0.4827922877708108
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,34891,335,0.72 [0.52-1.00],0.0519722563426465
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,34891,335,1.11 [1.01-1.21],0.0289168764486248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,35921,340,0.98 [0.78-1.23],0.8678331989198309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,40589,398,0.99 [0.93-1.06],0.861065515018782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,41274,403,1.04 [0.88-1.25],0.6299476942048456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,34795,332,1.08 [0.84-1.39],0.5373514909126813
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,40382,393,1.03 [0.92-1.15],0.6462492568791257
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,41333,409,1.29 [1.05-1.58],0.0157554914061394
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,35930,344,1.07 [0.78-1.46],0.6863946445225706
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,41323,407,0.96 [0.74-1.24],0.7617744948013928
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,41698,408,1.01 [0.89-1.16],0.8354806803740693
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,41323,407,1.44 [1.06-1.94],0.01802295463815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,35947,342,1.03 [0.92-1.15],0.604633108099434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,35870,341,0.90 [0.65-1.23],0.4902178016569084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,41555,412,1.61 [1.18-2.21],0.0028676600657138
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,41333,409,1.22 [0.90-1.65],0.2049130159901716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,40581,397,1.04 [0.87-1.24],0.6597326488581876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,34963,333,0.82 [0.59-1.14],0.2457538355597101
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,41689,410,0.91 [0.79-1.04],0.1489871253116249
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",35921,340,1.05 [0.91-1.22],0.4667169289165493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,35854,341,1.27 [0.94-1.71],0.1224473971595374
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,41206,402,0.93 [0.84-1.03],0.1641772012366252
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,41438,410,0.84 [0.71-1.00],0.0462769687007003
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,41274,403,0.80 [0.62-1.03],0.0873246518280709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,40382,393,0.93 [0.72-1.21],0.592704586366948
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,41323,407,0.95 [0.67-1.35],0.7872064571261231
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,41689,410,0.75 [0.50-1.12],0.1576513893723411
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,41323,407,1.00 [0.93-1.08],0.9251067727487502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,41274,403,1.01 [0.91-1.12],0.8480643635506739
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,35757,338,1.05 [0.95-1.16],0.3618282482363125
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,41629,408,1.06 [0.84-1.35],0.6187496017337173
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,41794,410,0.99 [0.86-1.14],0.9120465635489664
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,34974,334,1.12 [0.76-1.66],0.5562334149165653
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,34795,332,0.92 [0.74-1.14],0.428769404994248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,35706,338,0.98 [0.87-1.11],0.7718313318682605
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],41125,401,0.92 [0.78-1.08],0.2860751415562345
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,41333,409,1.06 [0.89-1.26],0.5060085603554809
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,34891,335,1.03 [0.90-1.16],0.696199372024598
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,34795,332,0.78 [0.54-1.13],0.1862672322989473
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,34795,332,1.15 [0.85-1.56],0.372778059480007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,40363,400,1.02 [0.81-1.29],0.8475827610518336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,34891,335,0.99 [0.70-1.40],0.9566771374303712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,40888,399,0.84 [0.73-0.97],0.0212725905804815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,35870,341,1.25 [0.99-1.58],0.0583199121302409
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,40301,398,1.09 [0.94-1.27],0.2448531788916491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,35263,335,0.98 [0.82-1.15],0.7701965194728814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,35768,339,0.98 [0.84-1.13],0.7627506024493663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,41125,401,0.97 [0.73-1.28],0.814633312213334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,41333,409,1.30 [1.06-1.59],0.0100989533667162
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,35263,335,0.96 [0.81-1.14],0.6407272427487496
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,33833,323,0.98 [0.89-1.07],0.5979408130479317
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,40920,404,0.95 [0.82-1.10],0.5011153447272308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,41484,405,0.98 [0.79-1.20],0.8197837885500772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,41125,401,0.92 [0.81-1.05],0.2055643905904372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,34824,331,0.85 [0.67-1.07],0.1688950855955937
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,35854,341,0.99 [0.90-1.09],0.8427003608177297
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,34974,334,0.97 [0.83-1.13],0.6573961138354376
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,41125,401,0.87 [0.71-1.07],0.1983724082349265
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,35847,342,1.07 [0.64-1.79],0.8076695996967338
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,35854,341,1.10 [0.86-1.41],0.4499330023603648
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,41356,404,1.33 [1.03-1.72],0.0314512342499623
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,41078,403,0.99 [0.87-1.12],0.8392651492189902
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,41555,412,0.99 [0.63-1.54],0.9571422040047728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,34963,333,1.01 [0.78-1.31],0.9442516758462008
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,34824,331,1.17 [0.98-1.39],0.0860148791598069
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,35768,339,0.94 [0.79-1.13],0.5056189933732584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,35870,341,1.02 [0.86-1.20],0.8099113475391295
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",34974,334,1.00 [0.85-1.16],0.9577954024291224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,41689,410,1.00 [0.94-1.06],0.9507312941146504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,41110,408,0.92 [0.73-1.16],0.475762702061726
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,34795,332,0.97 [0.82-1.15],0.7291018874079895
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,40581,397,0.96 [0.82-1.13],0.6356980169612656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,40301,398,0.86 [0.75-0.98],0.0258594154581108
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,41018,400,1.02 [0.93-1.10],0.7219412838645636
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,35870,341,1.01 [0.93-1.10],0.8188334392904966
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",35263,335,1.03 [0.84-1.27],0.7809079816910809
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40589,398,0.99 [0.85-1.17],0.9439989752892356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,34974,334,0.87 [0.67-1.13],0.2853925400171289
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,34602,329,0.94 [0.77-1.16],0.5871471269378481
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,40363,400,0.96 [0.83-1.11],0.5553256408003964
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,34891,335,1.38 [1.12-1.69],0.0020515306927949
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,35567,338,0.88 [0.63-1.24],0.4746921177616431
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,35854,341,1.06 [0.80-1.40],0.6822119106931505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,34795,332,0.98 [0.84-1.13],0.763119735180556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,41614,409,1.09 [0.80-1.50],0.574760084411841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,41333,409,0.86 [0.62-1.20],0.373589883851652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,40581,397,0.81 [0.67-0.99],0.0344924257761419
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,35263,335,1.00 [0.87-1.15],0.9875233675814694
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,41333,409,0.94 [0.80-1.12],0.5072880847947899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,41274,403,0.99 [0.85-1.16],0.9345963017083924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,35152,331,1.05 [0.83-1.32],0.7086383530241438
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,34667,329,0.92 [0.65-1.29],0.6330601010802195
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,40363,400,1.01 [0.84-1.20],0.9340691345256376
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,35768,339,1.16 [0.83-1.62],0.3995825363742268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,34824,331,1.07 [0.96-1.20],0.2308089866531524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,35078,331,0.93 [0.73-1.17],0.5315260343315745
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,35870,341,1.01 [0.87-1.16],0.9345170073612246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,41658,409,1.17 [0.78-1.74],0.4491138136319729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,35870,341,1.15 [0.77-1.73],0.4881546573241926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,41323,407,1.08 [0.85-1.37],0.5457317972074442
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,35768,339,0.83 [0.60-1.15],0.2575939390677671
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,35768,339,0.92 [0.68-1.24],0.5785142525180547
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,35757,338,0.91 [0.70-1.18],0.468352903046573
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,34667,329,1.02 [0.87-1.20],0.7629739273620832
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,35757,338,0.97 [0.77-1.22],0.8010371224791575
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,41828,413,0.98 [0.79-1.22],0.8555827221510479
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,35768,339,0.99 [0.87-1.14],0.9297201376031397
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,35921,340,0.98 [0.88-1.09],0.7243848399680595
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,41633,407,1.14 [0.93-1.41],0.2088720232760594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,41125,401,1.27 [0.96-1.67],0.093422429711319
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,41689,410,0.94 [0.81-1.10],0.4346423905120141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,41323,407,0.94 [0.84-1.06],0.2989309207371856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,34667,329,0.94 [0.76-1.16],0.5530467212474683
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",34667,329,1.01 [0.83-1.23],0.9138867655026552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",34795,332,1.11 [0.94-1.30],0.2156107149889503
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",35152,331,0.99 [0.90-1.10],0.9142540330331445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,41828,413,0.97 [0.87-1.10],0.6769258011908827
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,41484,405,0.96 [0.87-1.06],0.4538391446631937
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,40382,393,1.18 [0.86-1.62],0.3077312118070546
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,41323,407,1.10 [0.81-1.51],0.5322735416703493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,41828,413,1.02 [0.80-1.31],0.8634301677979986
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,34667,329,0.81 [0.61-1.08],0.1448689109063365
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,35152,331,1.23 [0.82-1.85],0.3090146448086353
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,35930,344,0.98 [0.82-1.16],0.7751833630921957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,34667,329,1.12 [0.95-1.31],0.1866138456976102
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,35870,341,0.99 [0.91-1.08],0.8472320980444724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,41484,405,1.01 [0.94-1.09],0.7365904736175152
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",40382,393,1.01 [0.84-1.21],0.9349350489561172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,34963,333,0.93 [0.75-1.15],0.4856017684330195
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,34667,329,1.07 [0.90-1.27],0.4639239276926584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,34795,332,0.99 [0.83-1.19],0.9428815372639812
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,34891,335,1.34 [1.08-1.67],0.0072905168875588
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,41828,413,1.25 [0.85-1.83],0.2590081028943683
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,41333,409,0.93 [0.80-1.09],0.3578868866826796
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,41333,409,0.88 [0.66-1.18],0.3997177607739766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,34974,334,0.67 [0.44-1.02],0.0631885411419097
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,35152,331,0.88 [0.62-1.24],0.4617883211227148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,35947,342,0.81 [0.55-1.21],0.3093576045768887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,34891,335,1.06 [0.98-1.16],0.151504362142752
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,35711,341,1.00 [0.90-1.12],0.9470300519013763
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,40363,400,1.03 [0.88-1.21],0.7005396682493483
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,34667,329,1.07 [0.88-1.30],0.4800855113769429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,34963,333,1.07 [0.92-1.24],0.4125119509757183
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",41058,400,1.00 [0.89-1.12],0.958308719798346
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,35947,342,1.08 [0.94-1.23],0.2631298311086985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",35921,340,0.97 [0.79-1.18],0.7358310223176378
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,41794,410,1.18 [0.84-1.67],0.3394940165892197
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,41630,412,0.93 [0.76-1.15],0.5186099481583777
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,35523,343,1.06 [0.75-1.51],0.7384241052905942
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,34795,332,1.07 [0.90-1.27],0.4539930624990336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,34963,333,1.03 [0.86-1.22],0.7655666423292831
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,34891,335,1.00 [0.90-1.11],0.9854792973915496
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,35870,341,0.97 [0.89-1.06],0.5311259429150834
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,35768,339,1.27 [1.04-1.54],0.0168507959909023
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,34667,329,0.96 [0.86-1.08],0.5412544990433836
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,41018,400,1.23 [0.91-1.66],0.1857084034022487
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,35152,331,0.94 [0.72-1.21],0.6248270379464027
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,35947,342,1.08 [0.71-1.65],0.7099430155938931
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PI3,Elafin,40788,408,1.15 [0.99-1.34],0.0623508608832488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",35870,341,1.00 [0.88-1.15],0.951365287756107
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,40814,403,1.41 [1.11-1.78],0.0045503550909922
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,41274,403,0.92 [0.80-1.07],0.2824928042429203
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,41333,409,1.30 [0.96-1.76],0.084984996010331
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,34891,335,1.03 [0.86-1.24],0.7392597083471554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,41333,409,0.98 [0.79-1.20],0.8131717380894273
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,41323,407,0.93 [0.80-1.09],0.3706586690903235
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,35152,331,0.96 [0.82-1.11],0.5678734156535374
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,34602,329,1.03 [0.90-1.18],0.6554501810830606
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,35921,340,1.00 [0.67-1.48],0.9818682649230946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,34795,332,1.00 [0.83-1.20],0.9798904186422024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,41353,402,0.83 [0.72-0.96],0.0096042941808177
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,35263,335,0.99 [0.86-1.14],0.8686591436595948
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,41018,400,1.13 [0.97-1.32],0.1159963520443019
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,41438,410,1.03 [0.75-1.43],0.8373238743189609
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,41765,413,1.08 [0.89-1.31],0.4319952630867268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",41233,406,1.13 [0.97-1.32],0.1123210897547729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,41484,405,1.04 [0.94-1.14],0.4999937812887445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,41333,409,0.69 [0.54-0.90],0.0055241988266545
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,41700,413,1.04 [0.87-1.23],0.6702975247216629
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,41333,409,0.85 [0.62-1.16],0.3054592802922368
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,41028,403,1.20 [0.88-1.65],0.2526316315454322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",35854,341,0.77 [0.65-0.92],0.0027917431258383
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",34891,335,1.07 [0.84-1.36],0.5882299344413924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",35854,341,0.97 [0.87-1.08],0.6012733179952909
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,35854,341,1.05 [0.91-1.22],0.5075416275758414
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,35063,339,0.84 [0.52-1.37],0.4888913521117722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,40363,400,1.05 [0.81-1.35],0.7203594033448062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,41323,407,1.11 [0.90-1.36],0.3251809910726607
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,41323,407,0.97 [0.85-1.10],0.6199925643001818
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,35794,339,0.99 [0.82-1.19],0.9014497469684084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,41681,411,0.80 [0.63-1.01],0.0627328771540524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,40382,393,0.82 [0.61-1.11],0.1948776504187436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,35854,341,1.41 [1.02-1.95],0.0394524828348417
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,41274,403,0.96 [0.86-1.07],0.4392192623145859
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,41643,412,1.49 [1.04-2.12],0.0283158725246823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,41196,407,1.05 [0.87-1.26],0.628774473875036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,41140,405,0.99 [0.95-1.04],0.825162827735801
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,34795,332,0.93 [0.81-1.07],0.3147338871493354
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,34795,332,1.08 [0.91-1.29],0.368882151710993
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,34963,333,1.18 [0.98-1.42],0.0769825915199756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,40296,400,0.95 [0.88-1.02],0.1694211901039982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,35947,342,1.01 [0.87-1.19],0.8584095820721801
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,35854,341,1.14 [1.01-1.30],0.0408936676080204
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,41283,403,1.00 [0.97-1.03],0.9695564379778092
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,34974,334,0.94 [0.78-1.14],0.5394939807603242
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,34824,331,1.01 [0.80-1.28],0.910303594890004
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40581,397,0.98 [0.90-1.06],0.5356868381428848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,41125,401,0.94 [0.53-1.68],0.8387802769965262
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,41438,410,0.93 [0.68-1.27],0.6353195751261548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,34891,335,1.24 [1.01-1.53],0.0436410536600815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,34891,335,0.96 [0.67-1.39],0.8278351451419835
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",41125,401,0.98 [0.76-1.27],0.887494212638992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,34974,334,0.97 [0.84-1.13],0.7194980903950683
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,35947,342,0.82 [0.57-1.19],0.3050448961735462
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,40589,398,1.33 [1.03-1.71],0.0264209545210526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,41484,405,1.07 [0.78-1.47],0.6668164607029945
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,35930,344,0.71 [0.54-0.94],0.0168438825666688
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,35707,342,1.03 [0.91-1.16],0.6748827788493288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,41689,410,0.98 [0.81-1.19],0.8584290389146851
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,41345,409,0.99 [0.90-1.08],0.7656358753784113
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,35263,335,0.98 [0.82-1.16],0.7991777381269438
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",35930,344,0.96 [0.82-1.14],0.6588181943090947
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,34891,335,1.10 [0.80-1.50],0.5669555767037379
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,40382,393,1.01 [0.76-1.34],0.9699997460005402
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,34891,335,1.01 [0.85-1.20],0.9165500775913002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,35921,340,0.99 [0.81-1.21],0.9123212099214988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,41125,401,0.89 [0.77-1.03],0.1127577840556816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,35757,338,0.99 [0.87-1.12],0.8300464818110657
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,41438,410,0.97 [0.89-1.06],0.5327392981265973
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,35263,335,0.92 [0.79-1.08],0.3308875293058324
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,35870,341,0.92 [0.81-1.06],0.2503422856790847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,35870,341,1.14 [0.89-1.46],0.2827470384986683
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,41323,407,0.99 [0.89-1.11],0.8813688371042431
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,41794,410,1.01 [0.92-1.11],0.8027580582593105
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,35768,339,1.01 [0.93-1.10],0.791755627640644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,41018,400,0.96 [0.77-1.19],0.6918868327400343
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,34963,333,1.00 [0.87-1.15],0.9631061836165729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,41243,406,1.02 [0.94-1.11],0.6693230859327125
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,40382,393,0.95 [0.81-1.12],0.5647191589416899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,34667,329,1.08 [0.71-1.64],0.7298722139218008
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,35930,344,1.19 [0.91-1.55],0.2052939611199175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,35757,338,0.76 [0.56-1.03],0.0795190252062855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,41578,412,1.29 [0.99-1.69],0.0583530922718406
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,40175,394,1.02 [0.92-1.12],0.7548197031429609
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,35345,339,0.88 [0.74-1.04],0.1285036574253586
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40581,397,0.95 [0.84-1.07],0.3996948462467865
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",41794,410,0.92 [0.81-1.05],0.2096886232123912
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,41698,408,0.86 [0.75-1.00],0.0502951086631903
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,40581,397,0.93 [0.68-1.27],0.6513867415148396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,41283,403,0.88 [0.61-1.28],0.511400575983771
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,35930,344,0.92 [0.75-1.13],0.4443663002218738
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,35930,344,0.77 [0.62-0.95],0.0155922586481264
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40581,397,1.00 [0.85-1.19],0.9576202485849992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,34963,333,0.77 [0.54-1.10],0.1500321213070863
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,41323,407,0.96 [0.87-1.07],0.4633917596354737
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,35782,339,0.95 [0.84-1.08],0.4530683404677996
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,40581,397,1.13 [0.93-1.37],0.2120334205637871
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,34795,332,0.98 [0.77-1.26],0.9009361716922698
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,35152,331,0.98 [0.90-1.07],0.6505223125173989
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,40382,393,1.03 [0.90-1.18],0.6641495222743357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,41689,410,1.05 [0.94-1.18],0.4011886309946185
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,35854,341,1.22 [1.00-1.49],0.0553436726740702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,41419,411,1.12 [0.79-1.58],0.526443240692179
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,34795,332,0.91 [0.65-1.27],0.5684219582259136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,41274,403,0.99 [0.84-1.17],0.9351997940616368
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,35977,343,0.99 [0.66-1.48],0.949832147254546
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,34904,331,1.09 [0.94-1.27],0.2362074378845138
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,34891,335,1.26 [1.03-1.54],0.0221862470853211
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,34974,334,0.99 [0.75-1.31],0.950182523521921
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,41479,412,1.15 [0.99-1.34],0.0741619561613046
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,34891,335,1.31 [1.01-1.70],0.0407414507514251
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,41196,407,0.96 [0.77-1.20],0.7179552034713499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,35854,341,0.94 [0.71-1.24],0.6685691568968963
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,41156,403,1.20 [0.97-1.48],0.0927826385363033
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,40363,400,0.99 [0.91-1.07],0.7480781825726925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,41698,408,0.98 [0.69-1.40],0.929830592137138
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,40278,402,0.91 [0.75-1.09],0.3058232686558303
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,35263,335,0.96 [0.67-1.38],0.8348356569871898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,35600,342,1.26 [0.88-1.81],0.2061556011875367
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,35768,339,0.85 [0.69-1.05],0.132514829826648
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,35768,339,1.03 [0.99-1.08],0.1250324870607995
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,41018,400,0.96 [0.89-1.03],0.252959795668879
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,41274,403,0.96 [0.84-1.11],0.59079367280115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,40382,393,0.97 [0.80-1.19],0.7887722838690361
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,34667,329,0.85 [0.59-1.20],0.3536959939703298
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,35870,341,0.79 [0.63-0.98],0.0317497414535771
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,34963,333,1.08 [0.90-1.29],0.4257397763451807
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,41125,401,0.82 [0.69-0.97],0.0202027698175419
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,40958,400,0.89 [0.70-1.13],0.3253008998062756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,40828,397,0.91 [0.71-1.16],0.4324794679241783
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,41274,403,0.86 [0.72-1.02],0.0793101136691155
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,34891,335,0.88 [0.72-1.06],0.1809418734834642
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,41274,403,1.01 [0.92-1.11],0.8352522318830004
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,40382,393,0.96 [0.82-1.12],0.5768736175297722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,33903,323,0.99 [0.89-1.09],0.8251702549623366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",40363,400,1.04 [0.78-1.40],0.7750242655105524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,41018,406,1.17 [0.89-1.54],0.2709843353794401
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,34626,333,1.14 [0.94-1.39],0.171989719655281
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,35921,340,0.97 [0.86-1.10],0.6576873486088384
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,34963,333,0.92 [0.81-1.05],0.2350324086182841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,41274,403,0.95 [0.75-1.21],0.6926056652519077
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,40363,400,0.93 [0.73-1.17],0.5302911055519046
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,40589,398,1.21 [1.02-1.44],0.0323269524514748
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,34891,335,0.99 [0.81-1.21],0.915749861192223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,41018,400,0.99 [0.89-1.11],0.9225072151852154
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,41423,404,0.97 [0.88-1.07],0.5744013315190555
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,34825,333,1.13 [0.88-1.46],0.3450283589404487
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,35921,340,0.85 [0.60-1.21],0.3653390635956308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,35930,344,0.77 [0.48-1.23],0.272442747351432
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,41828,413,0.79 [0.58-1.06],0.1192549038583554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,35768,339,1.12 [0.91-1.38],0.2961277388732032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,35768,339,1.18 [0.75-1.88],0.4752033942304047
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,41203,401,1.02 [0.70-1.47],0.9293271594365996
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40875,397,1.07 [0.82-1.40],0.6218217489895512
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,35854,341,0.88 [0.66-1.16],0.3589789840726544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,41828,413,0.89 [0.63-1.26],0.5231695123062523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,35921,340,1.20 [0.86-1.66],0.279211575876258
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,35152,331,0.97 [0.81-1.16],0.7741555410108834
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,40179,399,0.99 [0.84-1.17],0.9068758335265112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,35263,335,0.93 [0.72-1.20],0.57861034439511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,41274,403,1.01 [0.84-1.21],0.9177239293033442
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,41509,406,0.99 [0.91-1.07],0.7385610468422152
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,41689,410,1.12 [0.88-1.42],0.3497892688361768
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,35757,338,0.93 [0.77-1.13],0.48597172476069
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,40363,400,0.89 [0.74-1.06],0.1900045189711612
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,34974,334,0.95 [0.73-1.24],0.7304323664645122
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,34795,332,1.18 [1.07-1.30],0.0011097354603074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,35977,343,0.95 [0.75-1.20],0.6583997247047604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,41131,406,0.93 [0.75-1.14],0.4725635033235278
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,41383,412,0.99 [0.71-1.38],0.9648422824347284
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,35246,335,1.19 [0.96-1.47],0.1045155627101549
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,35921,340,0.92 [0.76-1.12],0.4124730339770801
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,35921,340,0.99 [0.90-1.09],0.8171269723811055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,35921,340,0.96 [0.85-1.09],0.5379913916794238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,35757,338,0.96 [0.81-1.14],0.6453361503008062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,34795,332,1.08 [0.92-1.27],0.3457459820448778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,40581,397,0.99 [0.88-1.10],0.8183764139588883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,34795,332,0.96 [0.84-1.09],0.5030574656706257
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,34824,331,0.92 [0.76-1.12],0.4294771810514929
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,35757,338,0.95 [0.75-1.21],0.6752960314467025
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,41274,403,0.78 [0.64-0.95],0.0138172086563513
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,40363,400,1.12 [0.95-1.33],0.1804530333680028
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,35152,331,0.97 [0.84-1.11],0.6449748904840547
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,40382,393,0.91 [0.78-1.08],0.2828783810692862
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,40581,397,0.93 [0.80-1.08],0.3274673604211918
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,34963,333,0.86 [0.72-1.03],0.1114033376765365
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,40382,393,0.99 [0.82-1.21],0.9467353354667156
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,35263,335,1.08 [0.90-1.29],0.4036014682309309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,34891,335,1.27 [0.90-1.79],0.1762369712974449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,35757,338,1.09 [0.90-1.33],0.3858393815012462
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,34974,334,0.83 [0.68-1.02],0.0770040283332527
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,34824,331,0.94 [0.68-1.30],0.7113400148050655
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,40382,393,1.10 [0.92-1.32],0.3042011994404252
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,34891,335,0.98 [0.84-1.15],0.806017524312137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,35263,335,0.95 [0.77-1.16],0.5941520280803461
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,40382,393,1.26 [1.01-1.56],0.0411225653963421
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,41555,412,1.18 [0.99-1.41],0.0661820193052553
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,40363,400,1.02 [0.78-1.33],0.8888791690454371
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,34667,329,0.92 [0.72-1.18],0.5161194735034976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,40382,393,0.90 [0.76-1.07],0.219948743130441
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,35870,341,1.20 [0.93-1.56],0.156860857686589
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,40357,398,0.84 [0.71-1.00],0.0537846486671304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,35870,341,0.96 [0.84-1.10],0.5821301863855763
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,34795,332,1.05 [0.84-1.31],0.6527492282141014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,34667,329,0.95 [0.75-1.20],0.646703131700513
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,34963,333,1.01 [0.87-1.17],0.8777462725108229
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,41125,401,1.09 [0.97-1.22],0.1536029735424167
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,41125,401,0.99 [0.84-1.16],0.8978011052845526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,35768,339,0.99 [0.84-1.17],0.9055137364393376
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,34891,335,1.06 [0.91-1.24],0.4278581451210183
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,34974,334,0.96 [0.87-1.07],0.500765657497483
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,35757,338,1.07 [0.88-1.30],0.5240327981639015
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,40589,398,0.88 [0.69-1.11],0.2767443860265302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,34974,334,0.78 [0.47-1.28],0.3229305961760436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,35870,341,1.10 [0.93-1.29],0.2608254715504781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,41078,406,1.23 [1.04-1.45],0.0132467566717215
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,41828,413,1.20 [1.04-1.38],0.0137065357252642
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,41828,413,1.12 [0.98-1.28],0.0981383842803993
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,35757,338,1.13 [0.87-1.45],0.3593212962147887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,41356,404,1.15 [0.97-1.36],0.1019534449465447
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,34891,335,1.00 [0.81-1.25],0.9821819436816692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,41333,409,1.11 [0.82-1.50],0.5019343275615256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REN,Renin,41323,407,1.09 [0.98-1.21],0.0962726068814002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,34891,335,1.10 [0.85-1.42],0.4785352979434318
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,34667,329,1.02 [0.76-1.38],0.8856515147872603
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,41125,401,1.00 [0.80-1.26],0.9802297619217424
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RETN,Resistin,41225,409,0.95 [0.77-1.17],0.6423475760539814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",34795,332,0.99 [0.79-1.23],0.9092347241287356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,35757,338,1.05 [0.65-1.72],0.832080584165965
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,35870,341,0.96 [0.84-1.10],0.5730652069813358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,35263,335,1.04 [0.89-1.22],0.6140369719678594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,41689,410,0.94 [0.72-1.24],0.6816139475656509
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,41689,410,0.94 [0.68-1.30],0.718051219347412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,35870,341,1.01 [0.85-1.20],0.8899914635075287
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,40581,397,1.09 [0.97-1.23],0.1627989494489527
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,40767,400,0.99 [0.92-1.07],0.7757162415651137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,34891,335,1.06 [0.86-1.31],0.6067715562272621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,35152,331,0.92 [0.74-1.14],0.449912099117541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,41576,407,0.90 [0.78-1.04],0.1637129552693888
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,35921,340,1.00 [0.90-1.11],0.939270523846362
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,34795,332,1.05 [0.91-1.22],0.5053075862723648
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,35870,341,1.01 [0.83-1.24],0.913658572059138
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,35091,330,1.08 [0.93-1.26],0.2870003997975667
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,35947,342,1.32 [0.90-1.94],0.1598862195667445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,34974,334,1.12 [0.90-1.39],0.304763669622324
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,41131,406,0.91 [0.84-0.99],0.0332871101601132
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,34767,332,1.41 [0.98-2.03],0.0679216579647941
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,35682,339,1.02 [0.73-1.42],0.9059993440407388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,35870,341,0.99 [0.80-1.22],0.913711450841164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,41643,413,1.15 [0.84-1.59],0.3863769731618234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,34974,334,1.24 [0.89-1.73],0.2102168824305589
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,34891,335,1.06 [0.82-1.36],0.6788655864483384
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,34891,335,0.97 [0.72-1.31],0.8408188735098818
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,35263,335,1.09 [0.94-1.26],0.252544744189594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,40382,393,0.98 [0.85-1.12],0.767994820651455
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,35263,335,1.05 [0.88-1.25],0.5836056356520674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,34974,334,0.87 [0.76-1.00],0.0580174466130818
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,41356,404,0.89 [0.61-1.29],0.5394160917139448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,41689,410,0.97 [0.66-1.42],0.8827997175604039
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,34974,334,1.39 [0.77-2.51],0.2765998393019506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,41323,407,1.09 [0.83-1.44],0.5388844894304252
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,41125,401,0.93 [0.75-1.15],0.5230225947023358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,34891,335,1.19 [0.87-1.65],0.2809127963675719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,35263,335,0.92 [0.79-1.07],0.2668634409213357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,34963,333,0.92 [0.70-1.21],0.558469271064114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,34974,334,0.87 [0.65-1.15],0.3205766006672318
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,34795,332,0.93 [0.71-1.21],0.5841160621848053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,34963,333,1.01 [0.93-1.10],0.774439430026518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,40382,393,1.11 [0.93-1.31],0.2469415230247106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,40382,393,0.97 [0.85-1.11],0.6627094236160609
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,34824,331,1.03 [0.92-1.15],0.6450821199376904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,41018,400,0.85 [0.66-1.11],0.246264438151709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,41698,408,1.13 [0.83-1.54],0.4436545379028899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,41125,401,0.92 [0.68-1.25],0.6039069601483124
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,34795,332,1.00 [0.81-1.24],0.9828019377124628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",35870,341,0.94 [0.84-1.05],0.2749766250868468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,41698,408,1.33 [1.04-1.69],0.0226224433091655
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,40382,393,0.99 [0.91-1.08],0.8788921753456471
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,41689,410,0.99 [0.86-1.13],0.8348310944110626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,34795,332,1.07 [0.81-1.42],0.6158051508431535
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,41006,405,0.93 [0.77-1.13],0.4920483473268356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,40745,401,0.89 [0.79-1.00],0.058905776394583
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,34891,335,1.38 [1.05-1.81],0.0219404559254633
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,35870,341,1.06 [0.88-1.29],0.5378012808766713
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,40301,398,1.12 [0.97-1.28],0.1166212576098957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,35757,338,1.12 [0.92-1.37],0.2494553893356186
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,41438,410,0.90 [0.77-1.05],0.1822894012676035
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,35870,341,0.95 [0.77-1.18],0.6499403708053759
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,40589,398,0.87 [0.74-1.04],0.1248982296954799
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,35977,343,1.26 [0.98-1.63],0.0751068515872166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,35870,341,0.93 [0.64-1.37],0.727230498094507
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,34824,331,0.94 [0.77-1.17],0.5952953953756884
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,41274,403,1.02 [0.90-1.15],0.7992240955362984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,35263,335,0.98 [0.85-1.13],0.7835926019019173
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,35797,340,1.01 [0.92-1.11],0.8052691219089927
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,34795,332,1.03 [0.78-1.36],0.8390916597937386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,34795,332,0.92 [0.74-1.16],0.4833499810229311
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,35263,335,1.11 [0.96-1.28],0.1686895683275896
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,35870,341,0.94 [0.66-1.34],0.7252293680608803
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,35861,343,0.99 [0.74-1.33],0.9465889420240292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,41125,401,0.98 [0.89-1.09],0.769115255877975
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,41689,410,1.11 [0.83-1.49],0.4733185835810081
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,40363,400,0.92 [0.77-1.09],0.3416698569647931
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,40241,395,1.28 [0.97-1.69],0.0852988461572238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,41828,413,1.08 [0.88-1.32],0.4781141667349039
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,41689,410,1.26 [0.93-1.71],0.1301674557262962
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,41507,407,1.20 [0.92-1.57],0.1760705149796873
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,41356,404,1.03 [0.79-1.34],0.835542082888847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,41358,405,0.99 [0.84-1.16],0.8707886868528508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,34795,332,1.05 [0.74-1.47],0.7928020587739175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,35152,331,1.36 [0.91-2.03],0.1394691990313359
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,41423,404,1.07 [0.97-1.19],0.1590896237146926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,40581,397,1.34 [1.10-1.62],0.0030649471988805
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,34824,331,1.01 [0.87-1.16],0.9134026478634916
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,41576,407,0.99 [0.82-1.19],0.8994271188747442
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,34824,331,0.99 [0.79-1.23],0.9093819517675872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,34963,333,0.83 [0.56-1.23],0.3469257562751268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,34963,333,1.07 [0.81-1.41],0.654787134080842
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,34824,331,0.88 [0.69-1.12],0.2813234034231662
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,34974,334,0.93 [0.72-1.19],0.556520600847316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,40382,393,0.95 [0.83-1.08],0.4087696296857381
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,34847,332,1.08 [0.87-1.33],0.4954982306382071
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,35921,340,1.28 [0.89-1.82],0.1824026982157787
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,34974,334,1.08 [0.97-1.20],0.1800222104965743
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,41274,403,0.97 [0.82-1.14],0.6975233367219562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCT,Secretin,34963,333,1.06 [0.85-1.32],0.5961773236400844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,41323,407,1.14 [0.91-1.41],0.2575189170390162
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,41323,407,0.96 [0.79-1.16],0.6660122636241415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,35757,338,0.98 [0.89-1.07],0.6590097913075885
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,35768,339,0.86 [0.72-1.03],0.1055961805244638
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,35152,331,1.01 [0.76-1.35],0.9190966008979314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,34974,334,0.97 [0.85-1.11],0.6599410801882135
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,34974,334,1.20 [0.90-1.60],0.2205838288959527
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,41828,413,1.11 [0.93-1.32],0.2394291353356222
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,35977,343,1.18 [0.76-1.83],0.4729679659264263
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,35977,343,0.84 [0.53-1.34],0.4690696753154788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,41479,412,0.96 [0.82-1.12],0.6200837768392798
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,41274,403,1.22 [0.87-1.72],0.2568763887372373
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,41323,407,1.27 [0.91-1.77],0.1606449512124197
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,35152,331,1.12 [0.89-1.42],0.3284320736062885
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,41125,401,0.90 [0.65-1.24],0.5106013556046642
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,41689,410,1.05 [0.79-1.41],0.7243773331659819
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,34891,335,1.19 [0.81-1.74],0.372996499631935
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,41700,413,1.13 [0.82-1.55],0.457133263461964
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,35870,341,0.99 [0.86-1.14],0.8763145527229271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,35263,335,0.95 [0.77-1.17],0.638987326635023
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,35781,341,1.05 [0.76-1.45],0.763155536922289
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,41125,401,1.06 [0.78-1.43],0.7177756127477404
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,35293,339,3.05 [1.09-8.50],0.0328826141493305
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,41828,413,1.07 [0.87-1.33],0.5180394731177573
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,40158,400,1.01 [0.93-1.11],0.7626513766763925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,35854,343,1.19 [0.61-2.32],0.6057689574647185
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,35309,340,0.80 [0.52-1.24],0.3246438872053398
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,35435,340,0.97 [0.69-1.36],0.8502646236329623
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,35977,343,1.51 [0.79-2.89],0.2104449541306056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,35977,343,0.79 [0.45-1.39],0.413394207796522
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,40916,401,0.96 [0.84-1.09],0.5027325818884605
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,41205,407,1.01 [0.91-1.11],0.9042965069596504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,40589,398,0.93 [0.78-1.12],0.4409012790910068
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,41554,408,1.10 [0.95-1.28],0.2154066136548351
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,41794,410,0.97 [0.83-1.13],0.6696327234841019
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,41018,400,0.89 [0.68-1.16],0.3873944317516309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,35908,343,0.96 [0.48-1.94],0.915404350242198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,35908,343,1.33 [0.92-1.92],0.1283169320486158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,41828,413,0.99 [0.87-1.13],0.9127657637398024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,35921,340,1.02 [0.87-1.19],0.8463420382836064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,35437,341,1.15 [0.78-1.69],0.4889916308782317
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,35293,340,1.64 [0.76-3.53],0.2081860846472374
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,35908,343,1.11 [0.64-1.95],0.7076874708990446
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,35263,335,1.00 [0.92-1.09],0.9444358795407476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,35082,331,0.92 [0.64-1.33],0.6672932090691372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,35768,339,1.17 [0.97-1.40],0.0974736161390849
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,40363,400,0.92 [0.80-1.06],0.2530123791917985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,40889,400,0.66 [0.49-0.88],0.0053373088432566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,34963,333,1.19 [0.85-1.67],0.3086925999861137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,41438,410,1.03 [0.75-1.41],0.8687131439731968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,41125,401,0.94 [0.64-1.37],0.7453988710890258
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,41125,401,0.96 [0.85-1.08],0.5136029150700843
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,40883,398,1.00 [0.81-1.23],0.9931533439196047
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,35152,331,1.04 [0.80-1.37],0.7504250940553743
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,40382,393,1.09 [0.94-1.26],0.2699743735156227
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,40382,393,1.00 [0.84-1.19],0.9924446913465944
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,41323,407,1.17 [1.02-1.33],0.0200548104939872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,35317,336,1.16 [0.97-1.39],0.1073241598100352
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,40382,393,1.01 [0.93-1.11],0.758226878067941
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,41274,403,0.86 [0.72-1.01],0.0690662478237336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,34824,331,0.96 [0.80-1.15],0.6454232102839913
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,35768,339,0.99 [0.80-1.22],0.9275702387651916
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,35062,334,0.99 [0.87-1.12],0.8450663495717018
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,35854,341,0.91 [0.78-1.07],0.2474839773141443
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,35947,342,0.90 [0.73-1.12],0.3506826511909383
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,34667,329,0.98 [0.90-1.08],0.7363336802977412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,34727,331,0.97 [0.86-1.11],0.6936221482346274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,34891,335,1.13 [0.89-1.43],0.3081548934511037
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,35930,344,1.30 [0.89-1.90],0.1797553682435561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",41423,404,0.96 [0.86-1.06],0.436617344050428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,35263,335,0.95 [0.73-1.23],0.6763827101793207
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,41373,410,0.98 [0.81-1.19],0.8312324341036489
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,41484,405,1.22 [0.99-1.51],0.0615699349815165
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,41274,403,1.08 [0.82-1.41],0.5876450749846396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,40363,400,0.95 [0.83-1.07],0.3899325644477058
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,41333,409,1.04 [0.96-1.13],0.309083489825063
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,41698,408,1.04 [0.79-1.35],0.7913588196956504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,41323,407,1.23 [0.90-1.68],0.1925739420365744
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,34974,334,1.20 [0.95-1.52],0.1230104450575523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,41639,408,1.12 [0.83-1.51],0.4515880736521198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,34974,334,1.05 [0.77-1.43],0.7632417642026471
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,41424,409,0.93 [0.80-1.07],0.3058732624558009
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,41213,401,1.11 [0.92-1.34],0.2729229444869622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,34891,335,1.03 [0.91-1.16],0.6623296864181845
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,41125,401,0.96 [0.87-1.06],0.453575437971998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",40363,400,1.10 [0.95-1.28],0.1982467878541953
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,40581,397,1.10 [0.94-1.29],0.2374823614763521
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,40941,399,0.96 [0.85-1.08],0.466831959644629
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,41484,405,0.98 [0.90-1.06],0.6032809650910407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,34795,332,1.16 [0.91-1.49],0.218789608883405
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,35870,341,0.99 [0.89-1.09],0.7744425667714732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,40581,397,1.15 [0.99-1.34],0.0771489491904133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,40382,393,1.04 [0.82-1.33],0.7404984888038543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,41274,403,0.94 [0.81-1.10],0.4514165182338251
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,40382,393,0.99 [0.83-1.17],0.8825704851149723
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,34795,332,0.99 [0.67-1.47],0.9667032056103072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,35757,338,0.95 [0.79-1.15],0.5999944646077191
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,40363,400,0.99 [0.85-1.16],0.9274498403001432
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,34963,333,0.98 [0.80-1.21],0.8759968446859937
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,40363,400,1.01 [0.89-1.16],0.852537383693332
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,34667,329,0.96 [0.80-1.16],0.687888232066864
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,34667,329,1.20 [0.99-1.46],0.058932260339566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,40363,400,1.16 [0.90-1.49],0.2442780300117642
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,41274,403,1.01 [0.85-1.20],0.9185997147699446
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,34963,333,1.00 [0.86-1.17],0.9575555351727796
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,35930,344,0.75 [0.60-0.94],0.0117829287890207
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,34795,332,0.94 [0.81-1.09],0.4228536723927508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,35152,331,1.01 [0.89-1.14],0.8901400642121559
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,35768,339,1.01 [0.82-1.24],0.9616712772115512
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",34667,329,0.95 [0.78-1.15],0.5844841000889838
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,40363,400,0.88 [0.74-1.06],0.1781507162584748
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,34891,335,0.80 [0.58-1.11],0.1887523389122915
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,41698,408,0.97 [0.78-1.21],0.7680413855648024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,40589,398,1.00 [0.77-1.29],0.9937646620376576
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,35263,335,0.92 [0.79-1.07],0.2646898671974467
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,35768,339,0.99 [0.87-1.12],0.8266958606036399
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,35660,341,1.04 [0.79-1.38],0.7683560749084422
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,40382,393,1.00 [0.89-1.11],0.9383912493883524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,35757,338,1.00 [0.86-1.16],0.9767345360075584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,35757,338,0.99 [0.81-1.21],0.8997282932787114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,41125,401,1.10 [0.70-1.73],0.684312250090272
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,40363,400,1.02 [0.90-1.15],0.7670424875386315
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,34667,329,0.93 [0.76-1.15],0.5093188544110807
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,35768,339,0.96 [0.80-1.14],0.6232239250034796
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,41698,408,1.26 [0.96-1.64],0.0903216667349847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,41484,405,1.07 [0.85-1.34],0.5644343274581485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,41479,406,1.03 [0.87-1.22],0.7319523364656131
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,34891,335,1.00 [0.83-1.21],0.998076354066036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,41414,403,1.04 [0.91-1.19],0.5333386016919699
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,35757,338,0.95 [0.82-1.10],0.4677046661014367
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,34824,331,0.96 [0.81-1.15],0.6799738145881846
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,35789,340,0.95 [0.85-1.07],0.4292314682175553
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,41323,407,0.99 [0.90-1.10],0.9161484049974242
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,34824,331,0.97 [0.77-1.21],0.7825955132765925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,41438,410,0.97 [0.88-1.06],0.4962330013157294
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,35870,341,0.96 [0.80-1.15],0.6388475880036388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,35152,331,0.95 [0.87-1.04],0.2821810619945759
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,41018,400,1.01 [0.88-1.15],0.8900161057304237
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",34974,334,0.93 [0.67-1.30],0.671381693528917
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',35854,341,1.03 [0.83-1.28],0.7541717000502434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,34795,332,1.05 [0.89-1.23],0.5932096943144318
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,35152,331,0.95 [0.78-1.15],0.5921855461144009
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,35768,339,1.01 [0.80-1.29],0.906788058446722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,35757,338,1.02 [0.90-1.15],0.7906578156644588
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,34974,334,0.81 [0.56-1.18],0.2755963506698741
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,41323,407,1.03 [0.90-1.17],0.6880195275600324
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],40494,399,0.85 [0.70-1.03],0.0951938442923943
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",41333,409,1.06 [0.84-1.34],0.6004685351763938
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,35947,342,0.95 [0.79-1.14],0.571810271213936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,35870,341,1.04 [0.81-1.34],0.7445027922514611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,40382,393,1.21 [0.94-1.56],0.1461268032823522
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,41504,405,0.95 [0.83-1.08],0.4076779907474519
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,41269,407,1.05 [0.83-1.32],0.6939290371309388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,41269,407,1.05 [0.84-1.32],0.6550204329179463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,34963,333,0.89 [0.71-1.13],0.3406636560545917
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,35804,340,0.89 [0.57-1.39],0.6061651634706928
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,34963,333,1.02 [0.69-1.52],0.9081170581687924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,35870,341,0.90 [0.63-1.30],0.5833783071023655
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,35870,341,0.99 [0.82-1.18],0.8758968605513772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,41438,410,0.97 [0.86-1.09],0.6120857759794769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,41341,411,0.76 [0.55-1.06],0.1048676123827204
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPART,Spartin,35152,331,0.99 [0.86-1.13],0.8562226052599752
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,35921,340,1.28 [0.94-1.73],0.1156438197589639
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,41333,409,1.38 [1.13-1.68],0.0014157601292921
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,35152,331,0.97 [0.72-1.30],0.8289088877853031
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,41274,403,1.07 [0.94-1.22],0.2971423465200834
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,41333,409,1.06 [0.82-1.37],0.6489124563286935
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,41698,408,1.12 [0.95-1.33],0.1835494541332509
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,34795,332,0.83 [0.60-1.15],0.2587400483313657
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,41201,407,1.06 [0.75-1.51],0.7348378159710311
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,41484,405,1.09 [0.87-1.36],0.4689177381238856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,35768,339,0.98 [0.92-1.05],0.6543324370824954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,41018,400,0.75 [0.53-1.05],0.0954847772716238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,41356,404,1.26 [0.96-1.65],0.0896309544086585
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,41142,407,1.15 [0.89-1.48],0.2932265604376822
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,41758,412,1.21 [0.99-1.47],0.056233434241804
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",34891,335,1.16 [0.91-1.47],0.2308114038784708
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,34667,329,1.04 [0.88-1.23],0.6537636807601417
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,35263,335,0.98 [0.86-1.11],0.7533839902351135
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,35854,341,0.92 [0.78-1.08],0.2902340478442533
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,40581,397,1.02 [0.93-1.12],0.6922270476561734
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",34824,331,0.90 [0.64-1.26],0.5377639676298095
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,35854,341,0.99 [0.75-1.30],0.938794997780426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,41369,410,1.00 [0.93-1.07],0.9860557754098526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,41125,401,0.94 [0.81-1.09],0.4200151132798301
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,41274,403,0.99 [0.89-1.10],0.901404735754643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,35921,340,1.02 [0.77-1.34],0.8975791533794057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,40363,400,0.92 [0.79-1.09],0.3397402452534492
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",34891,335,1.16 [0.88-1.53],0.3013663220943413
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,41269,407,1.03 [0.95-1.11],0.4686308080073634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,41479,412,1.06 [0.87-1.30],0.5593126685590267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,34667,329,1.13 [0.80-1.61],0.4865369715195246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,35768,339,1.08 [0.88-1.32],0.4570300790321823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,35152,331,0.90 [0.74-1.08],0.2565580393208287
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",41125,401,1.08 [0.88-1.33],0.4532364918294013
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",41828,413,1.19 [0.90-1.57],0.2285885530346809
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",34891,335,0.98 [0.79-1.22],0.8501755450947082
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,35930,344,1.23 [0.85-1.77],0.2707500818588826
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,35757,338,0.74 [0.54-1.01],0.0599897910882682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,40941,399,0.98 [0.85-1.13],0.7628306439939551
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,34891,335,1.09 [0.95-1.25],0.237392185668602
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,41125,401,1.00 [0.94-1.07],0.9806540454213546
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,34667,329,0.99 [0.84-1.16],0.8979695824536327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,41689,410,1.14 [0.94-1.38],0.1943360097217042
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,41277,408,1.22 [0.85-1.77],0.283542517406848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,34824,331,0.99 [0.85-1.15],0.874888031928907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,41266,407,0.95 [0.83-1.08],0.4294622267408037
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,40589,398,0.96 [0.84-1.08],0.4721279550759306
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,40363,400,0.99 [0.85-1.14],0.8409738197366062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,41323,407,1.03 [0.93-1.14],0.6122620658591058
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",34667,329,1.01 [0.90-1.13],0.8432114868059619
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,40382,393,0.96 [0.82-1.13],0.6189205191049085
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,34963,333,1.05 [0.82-1.35],0.6872058823903532
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,35854,341,1.02 [0.79-1.33],0.8657446732050643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,41125,401,1.01 [0.87-1.17],0.8887958462509082
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,34891,335,1.22 [0.98-1.52],0.0808501377723021
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,40382,393,0.97 [0.84-1.11],0.6433684030236878
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,34891,335,0.81 [0.65-1.01],0.0598307357013352
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,41274,403,0.97 [0.80-1.17],0.7407281960096055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,35870,341,0.94 [0.82-1.07],0.364954859801834
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,40382,393,0.93 [0.75-1.15],0.486141736382183
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,35768,339,1.02 [0.79-1.32],0.8880214665985571
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,40382,393,0.97 [0.87-1.09],0.6022501015913485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,41689,410,1.01 [0.94-1.08],0.8193830121368917
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,41274,403,1.04 [0.89-1.21],0.6218582438962139
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,34891,335,1.07 [0.93-1.25],0.3455357077464671
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,41689,410,1.00 [0.85-1.19],0.9761853612271504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",35870,341,1.01 [0.86-1.19],0.9041577122972112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,40589,398,0.92 [0.77-1.10],0.3494617250222646
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,41333,409,1.20 [0.89-1.61],0.2360201249121485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,35757,338,1.11 [0.86-1.42],0.4192511047290689
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,34965,331,0.99 [0.72-1.35],0.9410816305853046
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,34963,333,0.87 [0.73-1.04],0.1346610901218814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,35768,339,1.07 [0.80-1.42],0.6481472121349519
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,35152,331,0.96 [0.80-1.16],0.6842693207888624
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,34824,331,0.86 [0.70-1.06],0.1544949758332556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,35854,341,1.03 [0.81-1.33],0.7955594468983589
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,35921,340,0.99 [0.86-1.14],0.8990028521507057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,35263,335,0.97 [0.88-1.07],0.5610987966266985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,41125,401,0.99 [0.92-1.07],0.8538554466234569
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,36664,360,1.59 [1.16-2.18],0.0036339634918722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,35757,338,0.99 [0.76-1.28],0.9340975813785364
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,41125,401,1.07 [0.84-1.36],0.6087890945748231
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,34667,329,1.06 [0.89-1.25],0.5084936846792247
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,35798,343,0.91 [0.71-1.15],0.4187624386613934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,40581,397,1.09 [0.96-1.23],0.2057922284291398
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,35263,335,1.01 [0.85-1.21],0.8702222693516208
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,40363,400,0.98 [0.87-1.10],0.7101269215042052
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",34963,333,1.05 [0.92-1.20],0.4724150863824055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",35757,338,0.89 [0.68-1.18],0.4324756958655696
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,35854,341,1.00 [0.85-1.19],0.9698370185964168
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,40363,400,0.87 [0.71-1.07],0.1898849203411683
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,41125,401,0.97 [0.88-1.07],0.5708758827437215
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,41274,403,0.96 [0.85-1.07],0.4385923699672337
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,35152,331,0.98 [0.86-1.11],0.7155509503594294
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,41018,400,0.96 [0.88-1.05],0.423215696548048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,41018,400,0.96 [0.86-1.07],0.4422711192382607
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,40382,393,1.03 [0.93-1.15],0.5284696715088708
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,34963,333,1.00 [0.81-1.25],0.9806525809249704
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,40956,400,0.97 [0.89-1.06],0.4949930768263543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,40589,398,0.99 [0.89-1.11],0.9224315117300348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,35214,334,0.92 [0.67-1.26],0.601955093070992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,41758,412,1.06 [0.80-1.41],0.681586272660814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,35921,340,1.32 [0.98-1.78],0.0676368215260038
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,35263,335,0.98 [0.82-1.19],0.8613865392258285
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,35921,340,1.37 [0.97-1.92],0.0747195622863556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,40363,400,1.02 [0.96-1.08],0.4886006665385755
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",34963,333,0.93 [0.69-1.23],0.5952472524089654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,35757,338,0.95 [0.82-1.11],0.5263523547349882
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,40363,400,0.99 [0.89-1.10],0.8837150630247174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,34795,332,1.21 [0.97-1.51],0.0855095747575907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,41438,410,1.05 [0.71-1.56],0.8067917217278356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,34891,335,1.45 [1.05-2.02],0.0257599976540728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,35198,335,0.94 [0.84-1.06],0.3234075117785334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,34963,333,0.99 [0.82-1.20],0.9419534483302124
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,35263,335,0.90 [0.68-1.21],0.4993172500674007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,35977,343,0.68 [0.42-1.10],0.1159668910942654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,34824,331,0.95 [0.79-1.14],0.5840649969235282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,41145,407,1.10 [0.99-1.22],0.0828757886407396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,41423,404,1.17 [1.01-1.36],0.0392270126304514
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,41291,410,1.21 [0.99-1.48],0.0658310734030044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,41220,411,0.95 [0.71-1.27],0.7352742893416895
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,41311,409,1.21 [0.99-1.46],0.0578082785057225
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,41491,411,0.92 [0.73-1.16],0.463053916476678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,35757,338,1.00 [0.91-1.10],0.9579659412737318
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,41274,403,1.13 [0.94-1.36],0.2003671372616629
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,41720,409,0.99 [0.79-1.25],0.9354396876432464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,35757,338,1.11 [0.92-1.34],0.269162768044583
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,41082,407,1.04 [0.75-1.45],0.8023888578985561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,34891,335,1.33 [0.87-2.04],0.1863317687673269
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,41438,410,1.08 [0.83-1.40],0.5796495534910922
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,41828,413,0.94 [0.71-1.25],0.677917616032023
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,41261,407,0.91 [0.81-1.02],0.122190584698644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,35947,342,1.03 [0.70-1.53],0.8652459760382467
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,34602,329,1.04 [0.92-1.17],0.5114124012569725
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,41323,407,1.17 [0.86-1.57],0.3179572685025603
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,41333,409,1.31 [1.05-1.64],0.0181946795511054
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,41347,411,1.04 [0.86-1.26],0.6927670079536031
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,41135,405,0.90 [0.67-1.20],0.4801703177363199
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,40589,398,0.97 [0.77-1.21],0.7741514635510758
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,34795,332,1.03 [0.93-1.13],0.5884514737486788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,34627,333,1.03 [0.75-1.41],0.8600602847434756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,35691,338,0.94 [0.83-1.06],0.2828865989677492
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,41689,410,1.30 [0.96-1.75],0.0886790817677946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,40143,396,1.00 [0.93-1.08],0.8951545574081903
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,41828,413,0.97 [0.79-1.19],0.7773720203684824
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",40286,399,0.98 [0.81-1.19],0.8156789178354
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,35263,335,0.79 [0.58-1.07],0.1222003377603149
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,41479,412,1.12 [0.92-1.37],0.2625066122422083
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,35921,340,1.05 [0.81-1.35],0.728392015055823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,35854,341,0.99 [0.88-1.12],0.914066009456882
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,40883,407,1.28 [0.94-1.74],0.1141254925647675
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,35921,340,0.81 [0.52-1.26],0.3495552415930948
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,41484,405,1.00 [0.94-1.07],0.9326166443977898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,41333,409,0.84 [0.67-1.05],0.1322955103556443
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,41199,407,1.19 [0.80-1.78],0.3877394369664408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,41438,410,0.98 [0.88-1.09],0.666849066620611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,34824,331,0.83 [0.63-1.09],0.1793878005119447
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",35263,335,0.99 [0.78-1.25],0.9079486718301208
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,34891,335,1.31 [0.89-1.93],0.1764918411294395
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,35263,335,1.08 [0.69-1.70],0.731822975945792
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,41794,410,1.05 [0.91-1.22],0.4790861306671337
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,34891,335,1.37 [0.96-1.94],0.0827267547213579
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,34963,333,0.92 [0.75-1.13],0.4433828466102923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,35263,335,0.98 [0.81-1.18],0.8140168810543095
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,34795,332,1.04 [0.84-1.29],0.6939409366273847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,34795,332,1.13 [0.96-1.33],0.1437796443314256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,35768,339,0.97 [0.87-1.07],0.5191472789342518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,35757,338,0.97 [0.84-1.13],0.7082712923233225
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,34974,334,1.08 [0.92-1.28],0.3471425023819896
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,35870,341,0.87 [0.69-1.11],0.2672125388840611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,34667,329,1.02 [0.79-1.34],0.8563518484092504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,34824,331,0.97 [0.84-1.12],0.7084451754795984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,35781,341,1.23 [0.95-1.59],0.1160490059467074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,41125,401,1.15 [1.04-1.27],0.00481228881819
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,40822,400,1.15 [0.91-1.45],0.2434575483265426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,41333,409,1.01 [0.90-1.14],0.8116852882451779
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,41479,412,0.94 [0.79-1.13],0.5307232350560491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,40523,398,1.14 [0.92-1.43],0.2338663251404757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,35768,339,1.02 [0.82-1.27],0.84038472694264
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40581,397,1.03 [0.81-1.31],0.8109291786316066
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,35152,331,1.01 [0.85-1.20],0.9154136748122832
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,41018,400,1.06 [0.81-1.38],0.6914832516222613
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,41018,400,1.22 [1.06-1.41],0.0059384877864607
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,41399,407,0.89 [0.74-1.06],0.179652932425125
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,41794,410,1.30 [1.05-1.61],0.0178495429840271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,41283,403,1.12 [0.83-1.51],0.4689810691124955
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,41438,410,1.12 [0.87-1.43],0.3734323423701972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,41356,404,1.21 [0.92-1.58],0.176185678843372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40581,397,1.05 [0.84-1.31],0.6493147257011616
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,41356,404,1.17 [0.88-1.56],0.2866565584739025
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,35152,331,0.93 [0.71-1.20],0.5684756041714283
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,41698,408,1.08 [0.83-1.42],0.5533831362557494
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,41333,409,1.33 [1.00-1.76],0.0464914583043122
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,41333,409,1.21 [0.98-1.50],0.0734453191884482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,41689,410,1.22 [0.89-1.67],0.2139406969166484
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,41720,409,1.27 [1.01-1.60],0.0391791326533954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,41018,400,1.14 [0.98-1.33],0.0812138153165316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,41689,410,1.13 [0.93-1.37],0.2041612174895456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,41018,400,1.24 [1.00-1.54],0.050215454848519
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,41794,410,1.06 [0.76-1.49],0.7228392247179833
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,41274,403,0.98 [0.85-1.14],0.8007372029467759
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,41794,410,0.87 [0.64-1.18],0.3661213477345848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,41484,405,1.12 [0.80-1.56],0.5052430250784995
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,41758,413,1.44 [1.06-1.95],0.0190381214798142
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,41018,400,0.97 [0.84-1.14],0.7467900001309924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,35930,344,1.07 [0.81-1.42],0.6300840042578976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,35854,341,0.97 [0.86-1.09],0.6175559430657356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,35930,344,0.97 [0.77-1.23],0.8010778918957133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",40589,398,1.06 [0.95-1.19],0.2595789115872268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,35263,335,0.86 [0.64-1.17],0.3508786758261721
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,41018,400,0.92 [0.75-1.14],0.4641612001411742
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,41333,409,0.73 [0.52-1.03],0.0769215023028066
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,35921,340,0.97 [0.85-1.11],0.6791065979650072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,35768,339,0.97 [0.88-1.06],0.4803937438357027
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",34667,329,1.00 [0.81-1.25],0.9690711005554816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,34891,335,1.03 [0.90-1.17],0.6923259023046997
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,34974,334,0.94 [0.77-1.16],0.5629279867152148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,40382,393,1.11 [0.91-1.37],0.3003954171403279
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,34891,335,0.92 [0.81-1.05],0.2074983511382116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,34384,325,1.10 [0.89-1.34],0.3830527455926158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,40589,398,1.21 [0.94-1.56],0.1337635634626328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,34963,333,1.01 [0.74-1.38],0.9424341981000012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,34963,333,0.96 [0.74-1.24],0.7589526041825293
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,35152,331,0.98 [0.88-1.08],0.6145413126041747
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,35921,340,0.81 [0.56-1.18],0.265798448539483
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,34795,332,1.19 [0.96-1.48],0.1092702306867146
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,40382,393,0.94 [0.82-1.06],0.3127067314723449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,41023,402,1.07 [0.88-1.29],0.4919084023637673
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,35263,335,1.05 [0.93-1.20],0.4059491808022255
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,40363,400,0.92 [0.72-1.16],0.4774377734011135
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,34795,332,0.93 [0.74-1.17],0.5262696484355021
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,34667,329,1.04 [0.89-1.21],0.6344783255169357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,41731,410,1.12 [0.95-1.33],0.1816850452672166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,35870,341,0.95 [0.72-1.27],0.7409433967403732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,34891,335,1.75 [1.28-2.40],0.0005020683286875
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,40581,397,1.07 [0.94-1.21],0.3048311810189684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,41274,403,0.93 [0.81-1.05],0.2413189848229673
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",34891,335,1.05 [0.80-1.38],0.7036722201903935
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,34795,332,0.85 [0.67-1.09],0.2065540168486788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,35263,335,0.95 [0.83-1.07],0.3779267926996539
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,35930,344,1.05 [0.91-1.21],0.4844852558466849
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,41283,403,1.17 [0.99-1.38],0.0587746850432301
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,35947,342,1.08 [0.89-1.31],0.445427031740047
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,41333,409,1.10 [0.85-1.43],0.4684056020891781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,41698,408,0.97 [0.84-1.12],0.6768439838064888
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,41274,403,0.92 [0.82-1.03],0.1645741529005394
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,35193,335,0.98 [0.83-1.16],0.8246523166582919
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,35768,339,1.02 [0.93-1.12],0.6858851088330981
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,34667,329,1.04 [0.87-1.25],0.6575709085278694
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,34963,333,1.00 [0.86-1.15],0.9594518098863198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,41274,403,1.03 [0.93-1.14],0.5969635397542029
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,35757,338,0.97 [0.86-1.10],0.6420028289810968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,34795,332,1.03 [0.83-1.27],0.7894282886877793
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,34891,335,1.02 [0.88-1.17],0.8312299533331007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,35870,341,0.99 [0.85-1.16],0.9082819083768602
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,41323,407,0.96 [0.85-1.08],0.4620977337817882
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,40589,398,0.98 [0.84-1.14],0.781581551681162
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,34795,332,0.89 [0.68-1.17],0.4095785653942306
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,40589,398,1.14 [1.03-1.26],0.0127501254780235
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,34795,332,0.93 [0.74-1.16],0.498358463424983
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,34824,331,0.97 [0.87-1.09],0.6525613873567002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,35768,339,1.01 [0.91-1.12],0.863507229285007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,34891,335,1.02 [0.78-1.33],0.8832322451961734
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,40295,399,0.96 [0.86-1.09],0.5489389181976365
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,34963,333,1.09 [0.88-1.35],0.4240546780841466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TTN,Titin,34795,332,1.15 [1.00-1.32],0.0475916447012342
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,35589,343,0.89 [0.59-1.35],0.5943757750091396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,34824,331,0.89 [0.61-1.30],0.5563484510849321
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,35930,344,0.96 [0.85-1.09],0.5425377499584081
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,35263,335,1.02 [0.89-1.16],0.7957158958551467
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,41018,400,1.02 [0.92-1.12],0.7628270647465789
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,35343,334,0.87 [0.68-1.13],0.3007385329455728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,41438,410,0.96 [0.70-1.33],0.8253753688038098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,41689,410,1.08 [0.95-1.23],0.2314862341760044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,35854,341,1.02 [0.83-1.24],0.8808994593995161
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,34759,329,1.00 [0.90-1.12],0.973711035400008
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",41333,409,0.96 [0.80-1.17],0.7103301744012367
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,41062,405,1.00 [0.88-1.15],0.9469914016034244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,41323,407,0.85 [0.62-1.16],0.2955313177152887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",34891,335,1.05 [0.89-1.24],0.5911590400340584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,41125,401,0.78 [0.60-1.02],0.0656604139630595
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,35757,338,0.95 [0.66-1.36],0.7768979673684637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,35921,340,0.99 [0.84-1.18],0.924552490751692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,34891,335,1.10 [0.92-1.30],0.3005411615646729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,34795,332,0.90 [0.73-1.11],0.3261783089448767
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,35152,331,0.99 [0.85-1.16],0.8873632078270014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,35768,339,0.97 [0.90-1.05],0.4824133819517894
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,34795,332,0.96 [0.86-1.08],0.4829701925339361
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,34795,332,0.99 [0.73-1.35],0.961078705174567
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,41018,400,1.18 [0.94-1.49],0.1452739480949239
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,41698,411,0.98 [0.83-1.15],0.8221002015289344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,34891,335,1.04 [0.69-1.56],0.8582412822614987
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,34667,329,1.07 [0.88-1.29],0.5029071830958444
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,35757,338,1.05 [0.79-1.40],0.7313736609029959
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,35921,340,1.00 [0.89-1.12],0.9778727614784444
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,34824,331,1.08 [0.88-1.33],0.480648171697425
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,35196,334,0.98 [0.80-1.20],0.8227640233716458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,35152,331,0.98 [0.84-1.14],0.7735660277758154
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,34963,333,0.94 [0.80-1.11],0.45537945554263
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,41125,401,0.98 [0.89-1.08],0.711914703602675
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,35757,338,0.98 [0.85-1.14],0.7935831690540098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,35854,341,1.23 [0.95-1.57],0.1119612812144966
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,34795,332,0.89 [0.78-1.02],0.1011317198351162
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,40589,398,1.00 [0.91-1.10],0.9811478729814268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,40382,393,0.99 [0.83-1.18],0.9365518044957466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,40589,398,0.87 [0.72-1.05],0.1460756452388415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,34891,335,0.99 [0.87-1.11],0.8411004522603538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,41274,403,0.99 [0.89-1.10],0.8015843158354313
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,40665,402,1.05 [0.76-1.46],0.7497616811246491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,35947,342,1.00 [0.87-1.16],0.9872077508111226
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,41125,401,0.56 [0.35-0.88],0.0127054542743552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,34824,331,0.99 [0.89-1.11],0.9238218308475288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,41419,411,1.09 [0.79-1.52],0.5918632880886419
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,41689,410,1.18 [0.88-1.58],0.2631682565052901
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,34667,329,0.98 [0.86-1.12],0.7729447448987686
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,41670,410,1.07 [0.92-1.24],0.4048787089847609
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,34891,335,0.87 [0.60-1.25],0.4399063418926375
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,41438,410,0.94 [0.80-1.10],0.4210232041820461
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,41727,410,1.09 [0.86-1.38],0.4808023581296423
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,35870,341,0.94 [0.67-1.33],0.7372432607094914
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,40589,398,0.92 [0.86-0.98],0.0167984813697857
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,34974,334,0.84 [0.54-1.33],0.466318427137617
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,35921,340,1.19 [0.91-1.57],0.2063416625186203
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,41125,401,1.17 [1.02-1.34],0.0272748152473136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,35947,342,0.96 [0.84-1.11],0.597420819852327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,41125,401,0.92 [0.76-1.11],0.3694157867706515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,35263,335,0.93 [0.79-1.09],0.376531073900988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,41125,401,1.04 [0.93-1.16],0.4823358561200745
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,35757,338,0.95 [0.85-1.06],0.3922203702947369
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,41125,401,1.03 [0.92-1.16],0.5847346995601781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,35757,338,0.95 [0.69-1.30],0.7497000712023925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,34795,332,1.02 [0.74-1.40],0.8979911362699131
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,35757,338,1.19 [1.03-1.39],0.0209658179473088
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,41277,408,1.13 [0.92-1.39],0.2550075170661764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,41258,406,1.04 [0.90-1.19],0.6126176557623455
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,35854,341,1.00 [0.76-1.31],0.9872868430768408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,40363,400,0.98 [0.82-1.17],0.8024251865882255
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,35263,335,0.90 [0.69-1.18],0.4483123343694192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40589,398,0.94 [0.80-1.10],0.4366990247722359
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,41689,410,1.00 [0.88-1.13],0.9609564164516056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,40382,393,1.03 [0.76-1.38],0.8698374178481607
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,35152,331,0.92 [0.76-1.11],0.3770697509055192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,41635,407,1.07 [0.87-1.31],0.5399263809491606
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,34667,329,0.90 [0.77-1.05],0.1801392446212723
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,40872,399,1.07 [0.86-1.34],0.5305222974466475
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,35870,341,0.77 [0.59-1.02],0.0642932242996405
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,41828,413,1.04 [0.92-1.17],0.5127494634446182
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",41333,409,0.99 [0.78-1.25],0.9293977610570276
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,40581,397,0.96 [0.84-1.11],0.5951652360029701
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,40589,398,0.99 [0.90-1.09],0.9035911360246336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,40363,400,0.99 [0.89-1.11],0.9179969673288708
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,35854,341,0.98 [0.85-1.12],0.7300760898964274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,34891,335,1.08 [0.92-1.27],0.3546769503198368
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,35757,338,0.89 [0.65-1.20],0.4438899603080374
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,35033,334,0.95 [0.78-1.17],0.6278083704165327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,41634,407,0.90 [0.79-1.04],0.1574761541158788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,39208,384,1.28 [1.03-1.59],0.0261780139946426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40889,400,0.99 [0.80-1.23],0.9351588853636192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",41356,404,0.99 [0.76-1.28],0.9458447538185928
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,41698,408,0.77 [0.60-1.00],0.0508050567005805
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,40581,397,0.88 [0.64-1.20],0.4139091384149341
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,41018,400,0.95 [0.81-1.13],0.5756264308735506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,41698,408,0.99 [0.84-1.16],0.9100956888973224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,41626,413,0.98 [0.76-1.28],0.8998113105010634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,34891,335,1.09 [0.91-1.31],0.3323091577782031
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,41438,410,1.03 [0.95-1.12],0.4937027230635613
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,40363,400,1.01 [0.80-1.28],0.92183852628078
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,35854,341,1.05 [0.71-1.54],0.8136311567648518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",35768,339,0.97 [0.91-1.04],0.4445962239629859
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,41125,401,1.04 [0.96-1.12],0.3605472591472776
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,35757,338,0.93 [0.67-1.29],0.6760559913163622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,34795,332,0.89 [0.75-1.06],0.191827069308817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,40581,397,0.95 [0.86-1.06],0.3697851001227682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,35152,331,1.02 [0.88-1.18],0.7983281752901482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,34891,335,1.47 [1.03-2.09],0.0323285517499217
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,34891,335,1.11 [0.86-1.43],0.4399055236270018
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,40382,393,1.03 [0.91-1.17],0.6026997989713981
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,40589,398,0.92 [0.74-1.16],0.4836182624980381
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,34795,332,0.90 [0.74-1.08],0.256502380085484
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,35768,339,0.93 [0.83-1.05],0.2241024681555344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,35854,341,0.92 [0.66-1.29],0.636413665202281
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,34891,335,1.09 [0.84-1.42],0.5257404915471182
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,35263,335,1.04 [0.88-1.23],0.6259235244127477
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,35757,338,0.97 [0.85-1.11],0.66899010009793
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,35768,339,1.01 [0.87-1.17],0.8962522142929482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,35757,338,0.95 [0.78-1.15],0.5926368710671646
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,34974,334,0.98 [0.94-1.02],0.3551125887323044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,34667,329,1.04 [0.76-1.42],0.8256558452940346
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,34824,331,0.98 [0.88-1.10],0.775478669475597
